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ABSTRACT
LOW TEMPERATURE PLASMA FOR THE TREATMENT OF EPITHELIAL
CANCER CELLS
Soheila Mohades
Old Dominion University, 2017
Director: Dr. Mounir Laroussi

Biomedical applications of low temperature plasmas (LTP) may lead to a paradigm shift
in treating various diseases by conducting fundamental research on the effects of LTP on cells,
tissues, organisms (plants, insects, and microorganisms). This is a rapidly growing
interdisciplinary research field that involves engineering, physics, life sciences, and chemistry to
find novel solutions for urgent medical needs. Effects of different LTP sources have shown the
anti-tumor properties of plasma exposure; however, there are still many unknowns about the
interaction of plasma with eukaryotic cells which must be elucidated in order to evaluate the
practical potential of plasma in cancer treatment.
Plasma, the fourth state of matter, is composed of electrons, ions, reactive molecules
(radicals and non-radicals), excited species, radiation, and heat. A sufficient dose (time) of plasma
exposure can induce death in cancer cells. The plasma pencil is employed to study the anti-tumor
properties of this treatment on epithelial cells. The plasma pencil has been previously used for the
inactivation of bacteria, destroying amyloid fibrils, and the killing of various cancer cells. Bladder
cancer is the 9th leading cause of cancer. In this dissertation, human urinary bladder tissue with
the squamous cell carcinoma disease (SCaBER cells) is treated with LTP utilizing two different
approaches: direct plasma exposure and Plasma Activated Media (PAM) as an advancement to the
treatment. PAM is produced by exposing a liquid cell culture medium to the plasma pencil. Direct
LTP treatment of cancer cells indicates a dose-dependent killing effect at post-treatment times.
Similarly, PAM treatment shows an anti-cancer effect by inducing substantial cell death. Reactive
oxygen species (ROS) and reactive nitrogen species (RNS) have an important role in the
biomedical effects of LTP treatment. This study demonstrates the capability of the plasma pencil
to transport ROS/RNS into cell culture media leading to their activation. The effectiveness of PAM
against SCaBER cells is the highest when it is used immediately after preparation. It is found that

the killing effect of PAM decreases gradually over time, depending on the dose of plasma
exposure. Hydrogen peroxide is known as one of the most stable and impactful ROS in biological
systems. Measurements show that the plasma pencil generates a significant amount of hydrogen
peroxide in PAM. Interestingly, the concentration of hydrogen peroxide in PAM decreases
gradually over time, which correlates well with the decrease of PAM effectiveness with storage
time. While the effects of PAM treatment on cancerous epithelial cell lines have been studied,
much less is known about the interaction of PAM with normal epithelial cells. Effects of PAM on
non-cancerous Madin-Darby Canine kidney (MDCK) epithelial cells indicates that MDCK cells
are much more robust than SCaBER cells against PAM treatment. The dose of PAM, which causes
a widespread death in SCaBER cells, does not significantly impact viability and morphology of
MDCK cells. Time-lapse imaging of normal cells shows that PAM treatment inhibits cell
proliferation and random migration. In addition, immunofluorescence staining shows that PAM
treatment causes a significant reduction in the nuclear localization of proliferation marker, Ki-67,
without any damage to the morphological properties of cells including adhesions and cytoskeleton
function. This dissertation clearly demonstrates the capability of PAM treatment in inducing death
in cancerous cells that can be important for cancer therapy. Hydrogen peroxide is identified as an
important ROS responsible for the anti-tumor properties of PAM, although much additional work
remains to comprehensively understand all the involved ROS/RNS and their role in PAM
treatment.
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CHAPTER I
INTRODUCTION
I.1

NON-EQUILIBRIUM LOW TEMPERATURE PLASMA

Plasma is known as the fourth state of matter. It is composed of electrons, ions, reactive molecules
(radicals and non-radicals), excited species, radiation, and heat. In terms of temperature, plasma
can be divided into two regimes: 1. Cold or non-equilibrium and 2. Hot or thermal. In nonequilibrium plasmas, the temperatures of ions and neutrals are close to room temperature while the
energy of the electrons is very high. The collisions of the energetic electrons with the molecules
of the background gas lead to atomic and molecular dissociation, excitation, and ionization. Since
these plasmas are weakly ionized, the gas phase chemistry is maintained without an increase in the
gas temperature. Non-equilibrium plasma is often referred to as low-temperature plasma (LTP), or
cold plasma, where the gas temperature is close to room temperature. This feature makes nonequilibrium plasma sources attractive for many industrial applications. Material processing,
etching, and surface deposition are well-known examples of such applications. Operating at
atmospheric pressure and having biologically tolerable temperatures make LTP sources safe to
apply to thermally sensitive targets such as cells and tissues. Charged particles, reactive species
(radicals and non-radicals), and UV radiations may be implicated in many of the observed
biological effects when plasma comes in contact with microorganisms and living tissues. However,
mounting experimental evidence has shown that oxygen and nitrogen reactive species play a major
role [1-3]. Table 1 shows a list of reactive oxygen species (ROS) and reactive nitrogen species
(RNS) [1].
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Table 1, A list of various reactive oxygen and nitrogen species [1].
Reactive Oxygen Species (ROS)
Radicals

Reactive Nitrogen Species (RNS)

Non-radicals

Radicals

Non-radicals

Hydrogen Peroxide, H2O2

Nitric oxide, NO

Nitrous acid, HNO2

Hydroxyl, OH

Ozone, O3

Nitrogen dioxide, NO2

Nitrosyl cation, NO+

Hydroperoxyl, HO2

Singlet Oxygen, (O2 1 Dg)

Nitrate radical, NO3

Nitroxyl anion, NO−

Singlet, (1O2)

Organic peroxides, ROOH

Superoxide, O2

−

Alkyl peroxynitrates,
RO2ONO

Carbon dioxide radical,
CO2

Peroxynitrite, ONOO−

Alkyl peroxynitrites,

-

ROONO

Carbonate, CO3

-

Peroxynitrate, O2NOO−

Peroxyl, RO2

Peroxynitrous acid, ONOOH

Alkoxyl, RO

Peroxomonocarbonate,
HOOCO2−

I.2

BIOMEDICAL

APPLICATIONS

OF

LOW

TEMPERATURE

PLASMA
I.2.1

Cold Plasma Devices in Biomedical Applications

In the last two decades low temperature plasma has been used in various biological and medical
applications ranging from the inactivation of bacteria to wound healing and, more recently, in
cancer therapy [4-7]. Many LTP sources have been developed to date and each is utilized for a
specific biomedical application [8]. Depending on the desired application the plasma power
density, working gas mixture, and configuration of the plasma device can be modified. Following
is a brief introduction of some major plasma devices and their applications.
Generally, low temperature plasma devices are categorized into three groups as direct, indirect,
and hybrid plasma sources. Dielectric barrier discharge (DBD) and floating electrode dielectric
barrier discharge (FE-DBD) are examples of direct plasma sources. FE-DBD device [9] has a
similar operation to DBD, except the secondary electrode is the surface of a target tissue or skin.
This device was used in some in vitro experiments (sterilization) and in vivo experiments on
animals (wound healing and blood coagulation) [9-11].
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Plasma jets, plasma needles, and plasma torches are examples of indirect plasma sources. In such
devices plasma is generated inside a chamber and a plume of plasma drifts out of a nozzle through
the flow of a feeding gas [12, 13]. The volume of the treated area is small but can be increased by
multiplying the number of jets. The concentrations of plasma-generated species in indirect devices
are much smaller than in DBDs.
The MicroPlaSter is a microwave driven plasma torch that was used in clinical trials for wound
healing. It works with argon gas and an input power of 80-110 W [14]. Experimental results
showed the effectiveness of the MicroPlaSter in the inactivation of drug-resistant bacteria and
fungi [15, 16].
Another example of indirect plasma devices is atmospheric pressure plasma jets (APPJ). In these
devices, plasma can be generated by either one or two electrodes and the working gas is usually
helium or argon. The first LTP jet used in biomedical applications was developed by Laroussi and
colleagues. This jet device is known as the plasma pencil [17, 18]. The plasma pencil has been
used for the inactivation of bacteria and the killing of various cancer cells [17, 19, 20]. Figure 1
shows a photograph of the plasma pencil in operation. In addition to bacterial inactivation, plasma
pencil was used in a research to destroy amyloid fibrils. Amyloid fibrils are proteins which are
associated with some neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Results of
this research indicated that the plasma treatment induces severe damage to the fibril and causes
extensive breakage in the treated proteins [21].
kINPen 09 (INP Greifswald, Germany) is a single electrode APPJ driven by radio-frequency which
was applied in vitro for skin decontamination [22].
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Figure 1. Plasma plume of helium gas launched out of the plasma pencil is in contact with a
liquid sample.

One of the most recent designs of LTP sources is a combination of direct and indirect plasma called
Surface Micro-Discharge (SMD) or hybrid plasma. It is made of three layers: a dielectric material
that is sandwiched between a high voltage electrode and a grounded mesh electrode [23, 24]. The
ignited corona discharge surrounds the mesh and gaps between electrodes. This plasma source has
advantages of both direct and indirect plasma. Experimental results have demonstrated the
effectiveness of this device against highly resistive bacteria and microorganisms. Another example
of SMD devices is called self-sterilizing surface (SSS) electrode which is shown in Figure 2 [25].
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Figure 2. Arrangement of the self-sterilizing surface discharge (Reprint with the permission from
the publisher John Wiley and Sons) [25].

Different areas of plasma medicine
The scientific discipline that deals with the biological and medical applications of low temperature
plasma is known as Plasma Medicine. Plasma medicine is a novel discipline which includes the
following major areas of applications:
•

Inactivation of microorganism/pathogens: surface and liquid sterilization,
destruction of biofilms, and disinfection of biological tissues

•

Dental applications: oral plaque biofilm control, disinfection of root canal, and
tooth bleaching.

•

Wound healing: stimulation of cell proliferation, angiogenesis, and blood
coagulation.

•

Cancer therapy

I.3

LOW TEMPERATURE PLASMA FOR CANCER THERAPY

I.3.1

Previous Research on Plasma for Cancer Treatment

Recent investigations showed that low temperature plasma exhibits anti-cancer effects [26]. LTP
has been shown to induce cell death in vitro and cell growth arrest leading to tumor reduction in
vivo. Several studies showed the capability of LTP treatment to modulate oxidative stress in cancer
cells via direct plasma exposure or Plasma Activated Media (PAM).
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Stoffel and colleagues studied the effects of cold plasma on eukaryotic cells using what is called
the plasma needle [27, 28]. They studied cellular morphology, attachment, and viability at different
exposure times and plasma doses. The results on normal vascular and fibroblast cells showed a
dose-dependent cell death which is manifested by apoptosis at shorter treatment time and necrosis
at longer treatment time. Similar results were reported on non-small cells lung cancer (NSCLC)
[29]. According to this research, cell detachment occurred at the area of the direct impact of plasma
needle even after a short exposure time but the cells that remained alive could reattached to the
surface. Also, the presence of a thin layer of culture media inhibited the cell detachment. They
concluded that cell detachment by the plasma needle was the result of a physical process on the
cells [30].
Keidar and colleagues [31] treated normal mice fibroblast cells directly by plasma jet while cells
were covered with a thin layer of growth media. The results showed that plasma treatment affects
cell-surface attachment and cell migration rate depending on the intensity of the plasma treatment
[31]. Work on human liver cancer cells showed that the viable cells were detached after plasma jet
treatment and were reattached again to the surface after a short period of time [32].
The efficiency of cold plasma treatment against tumor cells grown in vitro has been reported on
human melanoma [33, 34], breast cancer [35-38], colon/rectum cancer [39-41], liver cancer [42],
leukemia [43], brain cancer [44, 45], prostate cancer, [20, 46] and other cancerous cells [18, 26,
47]. Most of the results show a dose-dependent effectiveness of plasma treatment. The cell death
mechanism investigations on many cell lines indicated that a lower dose of plasma exposure or
shorter time of treatment leads to apoptosis in some types of tumor cells; however, a longer
exposure time results in necrosis [34, 48].
Apoptosis or “programmed cell death” is a genetically determined elimination of cells. It is
considered as a vital component of various processes such as “normal cell turnover, proper
development and functioning of the immune system, hormone-dependent atrophy, embryonic
development and chemical-induced cell death” [49]. Necrosis is the alternative to apoptotic cell
death and is considered to be a toxic process. In fact, necrosis refers to a degradative process which
is associated with inflammation and is usually considered to be a non-desirable mechanism of cell
death [49].
In addition to the in vitro research, progress in the field continued through in vivo experimental
trials and the treatment of solid tumors [44, 50]. The first reports were published by [51, 52] on
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U87 glioblastoma tumor implanted in mice. This tumor is one of the most aggressive and resistant
to radio-therapy and chemotherapy. The results of LTP treatment after five consecutive days
showed a significant reduction in the size of the treated tumor and the extension of survival time
of mice. Similar results in the size reduction of tumors were reported in [50, 53-55] which were
mainly mediated by apoptosis. All in vivo experiments indicated that effectiveness of low
temperature plasma treatment on destroying cancer cells from different tumor types and implicated
that ROS generated by plasma as one of the main active agents in the process. [44].
Plasma Pencil Treatment of Non-adherent Cells
The first study on anti-cancerous effects of the plasma pencil in Laroussi’s group was on nonadherent cells. Barekzi and Laroussi studied the effect of direct plasma treatment on the viability
of the non-adherent leukemia cancer cells [43]. In this research, the human T-cells (CCL-119; aka
CCRF-CEM) with acute lymphoblastic leukemia was used. The cell culture media was RPMI1640 at neutral balanced pH. A sample of CCRF-CEM cells with a concentration of 1 × 106 cells
ml−1 was exposed to the plasma pencil and was incubated for subsequent cell viability
measurements using trypan blue exclusion assay. The results of cell viability immediately after
LTP treatment showed no killing of leukemia cells except for the 10 min treatment time which
suggests that a high dose of plasma could cause immediate killing of leukemia cells. However, the
results at longer post-treatment time at 12, 36, and 60 h indicated that as the exposure time of
plasma increases, the number of dead cells significantly increases. For example, 4 min exposure
time had an average percent viability of 22.3% after 12 h post treatment.
A further step towards the understanding of the anti-cancer effect of plasma is to evaluate different
cell types and cell lines. Different cells respond differently to the LTP treatment due to their unique
morphology, phenotype, function, cell resources, and organ of origin. This research concerns the
study of the effects of LTP treatment on the adherent epithelial cells.
Epithelial cells are adherent ones that cover flat surfaces and fill most of the cavities of many
organs of the body. Epithelial cells are different in size and shape but all are tightly packed together
with almost no intercellular spaces.
I.3.2

Biological Roles of Reactive Oxygen and Nitrogen Species

ROS/RNS or RONS (reactive oxygen and nitrogen species) are well known as disease-associated
agents, which interrupt the biochemistry of cells. An increase in the oxidative stress can cause
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DNA damage or mutation, lipid peroxidation, and protein oxidation [56]. In nature, ROS and RNS
are weapons of the immune system of plants and animals to fight against invasive bacteria,
microorganisms, and cancer cells. In particular, ROS are known as mediators of intracellular
signaling cascades and its excessive production can lead to oxidative stress, interruption in cell
function, and finally cell apoptosis or necrosis [57, 58]. As a result, a balance between oxidant
agents and intracellular antioxidant resources is critically important for a proper cell function and
regulation [1, 59]. An introduction of most known ROS and RNS and their properties will be
discussed in detail in Chapter II.
I.3.3

Conventional Methods in Cancer Therapy

Cancerous tumors are malignant tumors. They are results of abnormal cell division which are
invasive and can spread into surrounding tissues or travel to organs far from the original location.
Normal cells can stop dividing when they come into contact with the same cell type or go through
apoptosis when they are old. This mechanism prevents the abnormal growth in normal cells. In
contrast, cancerous cells fail to check and balance such steps to limit cell division. For instance,
cancer cells are able to ignore signals of the apoptosis process, which body uses it as a mechanism
to discard unneeded cells [60].
There are several types of cancer treatment including chemotherapy, radiation therapy,
immunotherapy, and targeted therapy [61]. Radiation therapy is an expensive treatment in which
a high dose of x-ray radiation is used to kill cancer cells or to slow down the growth [62]. Radiation
therapy not only kills cancer cells but also affects healthy surrounding cells which leads to side
effects like fatigue.
Chemotherapy is the use of drugs to stop or to slow growth of cancer cells which proliferate
quickly [62]. It not only kills fast-growing cancer cells but also kill normal healthy cells which
grow and divide fast such as skin, hair, bone marrow, and blood cells. Damages to healthy cells
are the main side effects of chemotherapy such as mouth sores, nausea, and hair loss.
Immunotherapy is a relatively newer type of cancer treatment which is not as widely used as
surgery, chemotherapy, and radiation therapy. In this method substances from the immune system
such as white blood cells are used to fight against cancer. Immunotherapy drugs are the small
molecule or monoclonal antibodies that are designed to mark cancer cells so the immune system
will be able to identify and destroy them [63]. The most common side effect of this method is the
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skin reaction to the injection area. However, in rare cases, it may cause severe, or even fatal,
allergic reactions.
Each therapy method is applicable for a specific type of cancer and it can be combined with one
or more methods. Almost all conventional cancer therapies are associated with serious side effects
to the patients and can reach a saturation level of their efficacy [61, 64]. More importantly, cancer
cells build resistance to these treatments methods leading them to fail to help the patient after an
initial benefit. Therefore, new cancer therapies are urgently needed in the fight to cure cancer.

I.4

OUTLINE OF PRESENT RESEARCH

This dissertation is organized as follows. Experimental setup, cell lines, cell cultures, and
experiment protocols will be explained in Chapter II. This chapter includes an introduction of
direct treatment as the initial approach to treating cancer cells and Plasma Activated Media as
advancement to the in vitro treatment. PAM is produced by exposing liquid cell culture media to
the plasma pencil and it can be as effective as direct plasma treatment in killing cancer cells. PAM
protocol is more amenable to characterize the plasma-generated chemical species in media and it
widens the scope of our investigations. Therefore, PAM protocol was followed in the experiments
presented in this document. To evaluate the effectiveness of PAM over time, aged-PAM will be
introduced and its effect on cancer cells will be examined. The concentrations of hydrogen
peroxide as an important ROS will be measured at different times after plasma exposure. The
relation between the effectiveness of PAM and the concentration of hydrogen peroxide will be
analyzed. To understand how plasma treatment affects non-cancerous cells, a normal cell line will
be examined. Time-lapse microscopy and immunofluorescence assay will be employed in order to
achieve a further characterization of PAM effects on normal cells. Results of the treatment of the
cancer cells will be shown in Chapter III. In this chapter, the results of measurement of hydrogen
peroxide concentration, apoptosis or necrosis identification, and the effect of plasma treatment on
DNA will be shown. In Chapter IV, the effects of PAM treatment on the normal cells will be
presented. Moreover, characterization studies on cell motility, proliferation, and morphology of
normal cells will be shown. The conclusion and suggestions for future investigations are presented
in the last chapter. This research received the Institutional Biosafety Committee (IBC) approval
under the title of “Biomedical Use of Cold Plasma”.
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I.5

CONTRIBUTION OF THIS DISSERTATION

This dissertation explores the anti-cancer properties of plasma activated media and the response
of normal epithelial cells to this treatment. A temporal evaluation is conducted on the effectiveness
of PAM in the treatment of urinary bladder cancer cells. Mechanisms of cell injury induced by
PAM treatment in cancer cells are identified. A correlation between the concentration of hydrogen
peroxide in PAM and the anti-cancer effects of PAM is elucidated. Finally, effects of PAM
treatment on cell viability, proliferation, and morphology of normal non-cancerous cells are
investigated. The data produced in this work and its interpretation are novel and contribute new
knowledge to the field of plasma biomedicine.
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CHAPTER II
MATERIALS AND EXPERIMENTAL METHODS
II.1

MATERIALS

II.1.1

Plasma Source

The source of plasma used in this research is the plasma pencil. As it is already mentioned, the
plasma pencil is a handheld plasma jet device which was developed by Laroussi and colleagues
for biomedical applications. It generates plasma moderately low temperature at atmospheric
pressure. In this context low temperature, refers to temperatures that are not harmful to biological
organisms and tissues. The rotational temperatures of N2C 3Πu derived from optical emission
spectroscopy measurement of nitrogen (N2) at SPS 0-0 band and Δʋ = −2 bands was used to
determine the gas temperature of the plasma pencil. Depending on the experimental parameters
the gas temperature was found to be below 400 K in most cases, which is tolerable for biological
cells and tissues [65, 66]. The plasma pencil is made of two ring-shaped copper electrodes
embedded in a dielectric cylindrical tube. Each electrode is attached to a surface of centrally
perforated alumina (Al2O3) disk. The diameter of the disk is 2.5 cm and diameter of the hole at the
center is 3 mm. The two disks are set parallel to each other. The gap distance between the two
disks varies from 0.3 to 1 cm. The working gas is introduced through a gas inlet at a desired flow
rate. Plasma is ignited in the gap by applying repetitive high voltage pulses to one of the electrodes
while the second one is grounded and the plasma plume emerges out of the nozzle. Figure 3 shows
the schematic of the plasma pencil and the experimental setup.
The high voltage pulse generating system is composed of a high voltage DC power supply
(Spellman SL, 1200 Watt maximum power), a high voltage pulse generator (DEI PVX-41,
maximum output voltage: 10 kV), and a single channel arbitrary function generator (Tektronix
AFG 3021). The flow of the working gas is controlled by a mass flow meter (Bronkhorst HighTech).
A high voltage pulse generator converts a high voltage DC input into a pulsed output. The function
generator controls the width and repetition rate of the pulses. The pulse generator in this setup is
capable of producing high voltage pulses up to 10 kV with a repetition rate up to 10 kHz and pulse
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width varying from 200 ns to DC. The rise and fall time of the voltage pulse is about 60 ns. The
electrical and chemical characterizations of the plasma pencil have been published previously
showing the identification of the various reactive species generated in the gas phase by means of
optical emission spectroscopy [65, 67-70].
For all experiments in this research, plasma was ignited with the following conditions unless
otherwise mentioned: voltage pulse amplitude of 7 kV, frequency of 5.00 kHz, and pulse width of
800 ns. The flow rate of He was 5.0 ± 0.1 slm (the gas velocity was around 3 m s−1). The distance
between the nozzle tip and media surface was ∼22 mm while the depth of media was ∼3 to 4 mm.

Figure 3. Schematic of the plasma pencil and the experiment setup.

II.1.2

Cell Lines and Cell Culture

Two adherent epithelial cell lines were used in this study: SCaBER (ATCC® HTB3™) cells from
urinary bladder tissue with the squamous cell carcinoma disease was purchased from ATCC
(Manassas, VA). SCaBER cells were cultured in MEM (Minimum Essential Medium) with 10%
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Bovine Calf Serum and 1% Penicillin/Streptomycin/Glutamine, all purchased from HyClone
(Logan, UT, USA). MDCK (Madin-Darby Canine Kidney, ATCC® CCL-34™) cells are normal
(non-cancerous) epithelial cells originally derived from a canine kidney which was generously
provided by Dr. Venkat Maruthamuthu (Department of Mechanical & Aerospace Engineering,
Old Dominion University, Norfolk, VA). MDCK cells were grown in EMEM (Eagle’s Minimum
Essential Medium, ATCC, Manassas VA) supplemented with 10% Bovine Calf Serum and 1%
Penicillin/Streptomycin/Glutamine. Cells were seeded in a 75 cm2 vented cell culture flask and
maintained at 37 ºC in a humidified incubator with 5% CO2. The media was replaced twice a week.
To harvest cells, 1 ml of trypsin-EDTA 0.25% (HyColne, Logan, UT) was used following standard
cell culture protocol [71]. Once a flask had reached a high confluence, it was used to make a cell
suspension with a desired density. A specific amount of the cell suspension was seeded into either
a 96-well, 24-well, or 6-well plate depending on the experimental protocol and the details will be
explained more in the experimental methods (section II.2). After seeding, cell culture plates were
incubated overnight at 37 ºC in a humidified incubator with 5% CO2 to provide a complete cell
adhesion to the cell culture plate. Figure 4 shows bright field images of a SCaBER cells and MDCK
cells acquired at 10X magnification. This research received the Institutional Biosafety Committee
(IBC) approval under the title of “Biomedical Use of Cold Plasma”.

Figure 4. Bright field images of SCaBER cells (left) and MDCK cells (right) at 10x magnification.
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II.1.3

Cell Viability Assays

Dye exclusion is a traditional method to assess the viability of cells and trypan blue dye exclusion
staining is one of the most common and standard methodologies. Nonviable cells take the dye in
and turn into a blue color while viable cells remain unstained due to their intact cell membrane
which prevents dye penetration. Therefore, viable cells are easily distinguishable from dead cells.
A 1:1 ratio of trypan blue dye (0.4%) and cells suspended solution was used. The number of live
and dead cells were counted using a hemocytometer under a bright field microscope (ACCUSCOPE® 3020). Figure 5 shows an image of SCaBER cells assayed by trypan blue exclusion
assay in which dead cells are differentiated from live cells by their color i.e. bright and colorless
cells are live and dead cells (arrow) are blue.

Figure 5. An image of SCaBER cells treated by plasma for 2 min after the trypan blue exclusion
assay. Live cells are bright as the dye cannot penetrate into an intact cell membrane while dead
cells are stained (arrow). The image is at 10x magnification.

The second method to assess metabolically active cells was the MTS assay which is a fast and
convenient colorimetric method. Cell viability was measured using The CellTiter 96® AQueous
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One Solution Cell Proliferation Assay (MTS) (Cat#G5421 Promega) following the manufacturer's
protocol. The solution reagent contains a tetrazolium compound [3-(4, 5-imethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an electron
coupling reagent (phenazine ethosulfate; PES). PES is a chemical stabilizer to enhance MTS
solution stability. Metabolically active cells (presumably by NADPH or NADH) reduces the MTS
tetrazolium compound into a colored formazan product that is soluble in cell culture medium.
In this assay, media in each well of a 96 well plate was replaced by 100 µl of fresh complete cell
culture media and, 20 µl/ well of the MTS solution was added. Cells were placed in an incubator
at 37 ºC in a humidified incubator with 5% CO2 for 1 hour. Absorbance was recorded at 490 nm
using a microplate reader (AgileReader, ACTGene, Inc.). To quantify the absorbance intensity
acquired from MTS assay, the number of live cells in control samples was counted using a trypan
blue exclusion assay and it was used to calculate cell number densities in PAM treated samples.

II.2

EXPERIMENTAL METHODS

II.2.1

Direct Treatment

In this experiment, cells were cultured in a 24-well plate and were exposed directly to the plasma
pencil. Cells were covered with a layer of liquid media during plasma exposure. The schematic of
the setup is shown in Figure 6. SCaBER cells were prepared at a concentration of 5×105 cells/ ml.
One milliliter of the cell solution was seeded in individual wells and the plate was incubated
overnight at 37 ºC in a humidified incubator with 5% CO2 while cells adherence was monitored.
Before plasma exposure, media in each well was replaced with 1 ml of fresh complete cell culture
media. Each well was treated by the plasma pencil for 2, 3, 4, and 6 min, then samples were
returned to the incubator for later viability analysis. The number of live/dead cells were counted
at 12 and 24 h post-treatment time using the trypan blue exclusion assay. To examine whether the
plasma pencil induces any cell damage immediately after treatment, the viability of SCaBER cells
was measured immediately after direct plasma treatment (0 h). In addition, the effect of helium
gas on cell viability was examined by treating SCaBER cells with a helium gas flow (flow rate of
5 slm) for up to 6 min without plasma ignition. Since no changes occurred in the viability of helium
treated cells compared to the control, it is concluded that helium gas does not impact cells viability.
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Figure 6. Direct plasma pencil treatment of cells seeded in a 24-well plate.

II.2.2

PAM Treatment

Another method to treat cells was investigated by using plasma activated media which was
produced by exposing cell culture media to LTP. This protocol provides an indirect treatment of a
sample and allows for later application. PAM protocol has an advantage compared to the direct
treatment protocol in which a cell culture plate remains in an incubator during the PAM preparation
time. This can minimize possible temperature-related stress (below 37 ºC) in cells. In addition, in
direct plasma treatment one cannot measure the concentration of chemical reactive species in
plasma treated media without considering their mutual interaction with cells.
To make PAM, in all experiments 1 ml of a fresh complete cell culture media in an individual well
of a 24-well plate was exposed to the plasma pencil for the designated exposure time. In PAM
treatment protocol, a suspension of SCaBER cells with a concentration of 4×105 cells/ ml were
prepared and 100 µl of the cell solution was seeded in each well of a 96-well plate.
The plate was incubated at 37 ºC in a humidified incubator with 5% CO2 overnight for eventual
PAM treatment at a later time. Once the media was exposed to LTP to create PAM, the old media
(which was used to grow cells overnight) on top of cells in a 96-well plate was replaced by 100 µl
of PAM. Cells were then stored in an incubator for MTS assay at 12, 24, and 48 h post PAM
treatment. In the control sample, the older media was replaced with fresh non-plasma treated
media. Figure 7 represents a schematic of PAM treatment procedure.
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Figure 7. Schematic of PAM preparation and cell treatment.

Most conventional cancer treatment methods harm or kill normal cells as well as cancer cells which
engender mild to severe side effects. To understand the practical therapeutic potential of plasma
in cancer treatment, it is crucial to investigate its effects on normal healthy cells.
To evaluate effects of plasma treatment on normal epithelial cells, MDCK (non-cancerous) cells
were studied. Similar to PAM treatment of SCaBER cells, a cell suspension of MDCK cells with
a concentration around 2×105 cells/ ml were seeded in each well of a 96-well plate and were
incubated at 37 ºC in a humidified incubator with 5% CO2 overnight. The viability of MDCK cells
was monitored at 12, 24, and 48 h post PAM treatment using the MTS assay.
The same media with the same chemical composition which was used to grow the cells was also
used to make PAM i.e. MEM PAM for SCaBER cells and EMEM PAM for MDCK cells. EMEM
PAM was used for treating MDCK cells because this cell line was found to grow better in this type
of culture media and therefore provided the best-growing condition for the control sample. The
chemical formula of MEM and EMEM are slightly different. EMEM contains more amino acid
compounds and 1 mM Sodium Pyruvate while MEM contains 2.2 g/L Sodium Bicarbonate
according to the manufacturer data sheet. It was assumed that the difference in the composition
does not have a significant effect on the final results and to validate our assumption the H2O2 was
measured in both plasma treated media. In addition, Kaushik et al. [72] reported that addition of
10mM Sodium Pyruvate in their investigated media resulted in 20% reduction in the effectiveness
of the PAM. However, 1mM sodium pyruvate in the EMEM media is 10 times lower than what
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was used in Kaushik et al. [72] experiment and accordingly its scavenging effect should be
negligible.
The pH of the cell culture media was measured with an Orion star A216 pH meter (Thermo
scientific, Beverly, MA, USA) before and after plasma exposure. The exposure time was from 1
to 10 minutes. The pH of the untreated media was around 7.4 while the pH of 10 min PAM was
7.4 ± 0.4 indicating that PAM remains at buffered pH even after 10 min treatment eliminating the
possibility of acidic side effect on treated cells. In addition, the temperature of the media was
measured before and after plasma exposure with a thermometer and no temperature increase was
observed.
In prior work, it was observed that PAM treatment has a dose-dependent cytotoxic effect on cell
viability which was measured at different plasma exposure time. Similarly, diluting PAM with
non-treated media may reduce the concentration of LTP-generated reactive species and the
effectiveness of PAM against cells. To evaluate the validity of this hypothesis, effects of diluted
PAM on SCaBER cells viability were measured. Because of its pronounced killing effect 4 min
PAM was selected for making aliquoted PAM. MEM PAM was prepared by 4 min plasma
exposure and it was diluted with the untreated media to make the following dilutions: 1:1 (the
portion of PAM to the total volume), 1:2, 1:4, and 1:8. In fact, 1:1 is just 4 min PAM, 1:2 is 1 part
PAM and 1 part media, etc. The Aliquoted PAM was immediately used to treat SCaBER cells
following the same procedure used in PAM treatment and the viability was measured at 12 and 24
h post treatment using MTS assay.
In the next experiment, the potency of PAM against SCaBER cancer cells was compared to that
of an apoptosis-inducing drug, staurosporine (cat# 569397, EMD Millipore Corporation). To
accomplish this, 5×105 cells per ml of SCaBER cells were grown overnight in a 24-well plate.
Then, cells were treated with 1 ml of media that contained 1 µM staurosporine and 1 ml of 4 min
PAM while the control sample did not receive any treatment. Cell viability was analyzed at 10 and
24 h post treatment using the trypan blue exclusion assay.
II.2.3

Aged-PAM Treatment

Reactive oxygen species and reactive nitrogen species generated by the LTP in the gaseous state
or liquid state have specific but different lifetimes. In liquids, some species have very short
lifetimes as low as micro to nanoseconds. These include molecules such as OH radical, superoxide
anion (O2-), singlet oxygen, and nitrite (NO2-) while others have relatively longer lifetime such as
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hydrogen peroxide and nitric oxide (NO) [73]. Since the anti-tumor effect of plasma is highly
linked to the concentrations and lifetimes of RONS, knowledge of these quantities in PAM is
important as they directly correlate to its efficacy. Therefore, two questions arise: Will PAM retain
its anti-tumor property over time? How long after plasma exposure does PAM remain effective
against cancer cells? Measuring the efficiency of PAM at various times after preparation allows
for an insight into the temporal presence and stability of RONS in PAM.
To investigate the effects of aged-PAM, the MEM PAM was maintained in the dark at room
temperature for a designated time before using it to treat SCaBER cells. In this experiment,
SCaBER cells were prepared similarly to the application of immediate PAM. However, in this
case PAM was stored (or aged) 1, 8, and 12 h before application. The viability of cells was
measured at 12, 24, and 48 h post aged-PAM treatment using MTS assay. Figure 8 shows a
schematic of the aged-PAM protocol.

Figure 8. Aged-PAM preparation: PAM was stored at room temperature for a designated time
before applying in cell treatment.
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II.3

REACTIVE OXYGEN SPECIES IN PAM

II.3.1

Types of Reactive Species

Reactive oxygen species are radical or non-radical reactive molecules containing oxygen. ROS are
strong oxidants which react with most biomolecules and could produce a chain of secondary
reactions. Interaction of plasma with cells causes an oxidative stress which is associated with
damage to macromolecules such protein, nucleic acids, and lipids [74]. For instance, hydrogen
peroxide, H2O2, and superoxide, O2˙− , can cause hundreds of modification to proteins. On the other
hand, reactive species are natural byproducts of intercellular reactions such as in metabolic
processes [74]. The two-edged sword role of ROS was revealed by two discoveries in the 1970s
and 1980s; first, the toxic role of superoxide released from phagocytes via NOX enzyme (NADPH
(Nicotinamide adenine dinucleotide phosphate oxidase) and second, the beneficial messenger role
of ROS in peptide signaling [75]. A low concentration of ROS is beneficial for cells and has an
important role in regulating cell signaling pathways and affect cellular processes such as
metabolism, proliferation, differentiation, survival processes (like apoptosis), antioxidant
response, and DNA damage response [42, 74]. However, at higher concentration and when ROS
level overwhelms the cells’ antioxidant capacity, irreversible cell injury or death occurs, depending
on the cell type and environmental conditions. A cell type with a higher antioxidant capacity can
overcome a specific level of ROS that is harmful for another cell type. What is important is the
balance between antioxidant capacity and ROS level and accordingly, one can determine the
consequence of an “oxidative stress” in cells [76]. The followings are the most important ROS in
biological systems: O2- , H2O2, hydroxyl radical (˙OH), and singlet oxygen O2 (1Δg).
The existence of the superoxide radical was proposed in 1933 according to quantum mechanics
theory [77]. The superoxide anion is the precursor of the majority of reactions due to its high
oxidation-reduction ability. One of the most famous reactions of superoxide anion is dismutation
reaction in which O2˙− dismutate to hydrogen peroxide:
2O2˙− + 2H+ → H2O2 + O2

(1)

Superoxide dismutase (SOD) is an enzyme that catalyzes this reaction in cells. It is an antioxidant
defense mechanism which converts the highly toxic O2˙− into the less toxic H2O2 [59]. The
discovery of SOD led to the recognition of ROS biological functions [78].
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Hydrogen peroxide was produced as a disinfectant for the first time in early 1800 and because of
its oxidative properties, it was not considered to have a role in normal cell signaling [78]. Hydrogen
peroxide is commonly used in household products such as bleach-free cleaners, toothpaste, and
hair products. It is an important ROS by being able to penetrate the cell membrane. It is not a
radical species but it intermediates in many reactions and results in more ROS production such as
OH• [59]. Hydrogen peroxide with an oxidation potential of 1.8 V has a relatively higher stability
than other ROS species [73]. There are four known pathways to detoxify hydrogen peroxide in
cells including glutathione peroxidase, catalase, peroxiredoxin enzymes, and non-enzymatic
method by reacting with thiol proteins [73, 79].
Hydroxyl radical is probably the most reactive ROS. Having the half-life of 10-9 s in comparison
with the 10-5 s for superoxide anion and ~60 s for hydrogen peroxide, OH• is probably the most
short-lived ROS [73].
OH• causes significant damage to biological macromolecules. Hydroxyl radical is a powerful and
non-selective oxidant which can react with almost every organic compound [73]. Formation of
hydrogen peroxide from two hydroxyls occurs as follows:
OH + OH + M → H2O2 + M

(2)

Singlet delta oxygen in liquid media has a lifetime in the range of 10-3 to 10-6 s, depending on the
solvent composition. Singlet oxygen is less stable than the ground state oxygen as it is in the
excited state of the oxygen molecule in which two electrons occupy the same orbital with the
antiparallel spins [73]. Singlet oxygen is considered to be cytotoxic to eukaryotic cells, bacteria,
and viruses by its adverse effects on biomolecules such as DNA, proteins, and lipids [80]. Usually,
its generation in biological systems is via photo-excitation in which specific organic molecules
absorb a particular wavelength and produce singlet oxygen [73].
The second important category of biologically reactive species are the reactive nitrogen species
(RNS) such as nitric oxide (NO or NO•), nitrite (NO2−), nitrate (NO3−), and peroxynitrite (ONOO−).
Reactive nitrogen species react to form different products containing nitrogen oxides such as
nitrated fatty acids. Other than oxidizing of macromolecules, RNS play roles as signal transduction
mediators. These products can then react to make a cascade effect in biochemical cycles. For
instance, a presence of nitrite in human perspiration in a slightly acidic environment of skin will
create NO which acts as an antibacterial [81]. NO is an important reactive species in cell signaling
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pathways. NO is a diffusible radical which is involved in the circulatory system and results in
widening of blood vessels (vasodilation) and also its by-products play role in the nervous system
functions [82]. It is also the precursor of many reactions such as the formation of NO2• and ONOO−
[73]. Peroxynitrite protects organisms from pathogens; however, its overproduction is harmful and
leads to oxidation of proteins, lipid peroxidation, and DNA and mitochondrial damage [82].
As it is described above, some of the LTP-generated species have short lifetimes and cannot
penetrate deep into liquid media. However, due to their high reactivity, they interact with the liquid
and generate relatively stable long-lived species in the bulk of the liquid. These include hydrogen
peroxide, nitrites, nitrates, and organic peroxides. In particular, hydrogen peroxide is known to
cause various oxidizing reactions in biological cells, including the peroxidation of lipids and
induction of DNA damage. Hydrogen peroxide is also known to play a role in mitogenic
stimulation and cell cycle regulation [83, 84]. Because of the ability of hydrogen peroxide to
penetrate the cell membrane and its relatively long lifetime, its concentration was measured over
time in PAM.
II.3.2

Measurements of Hydrogen Peroxide in PAM

To measure the concentration of hydrogen peroxide generated in PAM, an Amplex red hydrogen
peroxide assay kit was used (Molecular Probes, Invitrogen, Burlington, Ontario, Canada). This kit
contains an Amplex red reagent, dimethylsulfoxide (DMSO), 5X reaction buffer, horseradish
peroxidase, and hydrogen peroxide. This kit must be stored at -20 ºC and protected from light for
optimal use. The Amplex red reagent is one of the most commonly used to measure concentrations
of hydrogen peroxide. The reaction of Amplex red reagent with hydrogen peroxide in the presence
of horseradish peroxide (HRP), which plays the role of a catalyzer in this reaction, results in the
production of resorufin. Resorufin is a colored compound that can be detected fluorometrically or
spectrophotometrically.
In all experiments, each plasma treated sample was diluted 1:10 with a fresh complete media to be
within the acceptable range of the assay. The control sample was a complete media with no plasma
treatment. A standard curve of known H2O2 concentration was prepared from a 3% hydrogen
peroxide stock solution (in complete cell culture media) within the range of 0 to 50 µM. The
standard curve was used to convert the acquired absorbance into concentration (µM). 50 µL of all
samples including PAM, control, and standard curve were transferred into individual wells of a
96-well plate. 50 µL of the working solution composed of 100 µM Amplex red reagent and 0.2
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U/mL HRP was loaded in each well. Then, the 96-well plate was incubated in a dark place at room
temperature for 30 min. The absorption of samples was measured at 570 nm using a microplate
reader (AgileReader, ACTGene). Moreover, to record the fluorescent light intensity, a
fluorescence microplate reader (BMG Labtech FLUOstar) was used with an excitation wavelength
of 570 nm and an emission wavelength of 590 nm.
The H2O2 concentration was measured in MEM PAM immediately after plasma exposure and in
aged-PAM after 1, 8, and 12 h in order to evaluate degradation of H2O2. To evaluate the effect of
serum on H2O2 concentration, a serum-free PAM made by MEM and 1% antibiotics was used and
the H2O2 concentration was measured after 8 h aging. Correspondingly, the H2O2 concentration
was analyzed in EMEM PAM immediately after plasma exposure.

II.4

LEVEL OF CASPASE-3 IN PAM TREATED SCABER CELLS

Caspases are part of a large family of cysteine proteases that mediate apoptosis. Upon activation,
endoproteases such as caspase-3 cleave a variety of target proteins in cells that causes
morphological and functional changes in cells undergoing apoptosis [85]. Some of the
morphological changes attributed to this process are evident in the cell morphology and adhesion
characteristics. The mechanism of apoptosis is very complex but all apoptosis pathways end up to
a same final execution pathway: the cleavage of caspase-3 which leads to “DNA fragmentation,
degradation of cytoskeletal and nuclear proteins, cross-linking of proteins, formation of apoptotic
bodies, expression of ligands for phagocytic cell receptors, and ultimately uptake by phagocytic
cells” [49]. Hence, monitoring the level of caspase-3 is a good indicator of the apoptotic pathway
activity [86, 87].
In order to elucidate the mechanism of cell injury in plasma treated SCaBER cells and ascertain
the underlying molecular mechanisms involved, the caspase-3 activity was investigated. The
caspase-3 activity was measured by ApoAlert1 Caspase Colorimetric Assay Kit (Clontech
Laboratories, Inc.). SCaBER cells were seeded in a 24-well plate and were treated with 1 ml of 2
min PAM. Positive control was treated by 1 µM staurosporine (STA) and negative control did not
receive any treatment. The control, STA, and PAM treated cells were collected at 4, 6, and 10 h
after treatment, were counted to supply at least 2×106 cells/ml, and were centrifuged at 2,000 rpm
for 5 min following the instructions provided by the manufacturer. Cells lysate was prepared by
adding 50 µl of Cell Lysis Buffer to cells pellet and were incubated in a 4 ºC fridge for 10 min.
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Then, it was centrifuged for 10 min at 14000 rpm and the supernatant was collected. 50 µl of the
supernatant from treated and control samples were mixed with 50 µl of the reaction solution (2X
Reaction Buffer/DTT Mix) and 5 µl of caspase-3 substrate (1 mM DEVD-pNA). Samples were
incubated in 37 ºC water bath for 1-3 h for eventual absorbance measurement at 405 nm using a
microplate reader (AgileReader, ACTGene, Inc.). The results are expressed as an absorbance (a.u.)
of each sample compared to the control sample.

II.5

EFFECT OF PLASMA ON REATTACHMENT OF SCABER CELLS

The morphology of the cells and their ability to reattach to the cell culture plate were evaluated
after direct plasma treatment. In this experiment, 1 ml/ well of SCaBER cells suspension was added
in a 24-well plate and each well was treated with the plasma pencil for 2 and 5 min immediately
after seeding and prior to active cell attachment. The control samples did not receive any plasma
treatment. The attachment of cells to the surface of the culture plate was monitored and photos
were taken using a bright-field microscope at 0 h (after seeding of cells), 1.5, 3, 4.5, 6, and 24 h
after plasma exposure. Between these imaging times, the cell culture plate was stored in an
incubator at 37 ºC humidified with 5% CO2.

II.6

TIME-LAPSE IMAGING OF THE MDCK CELLS

Results of PAM treatment on MDCK cells suggested that LTP affects cell proliferation in normal
cells. These preliminary results on MDCK cells were encouraging and add a profound
understanding of how PAM treatment impacts cell proliferation and migration. Time-lapse
imaging was used to monitor changes in cells during PAM treatment. Here, MDCK cells were
seeded at 8×104 cells per well in a 24-well plate and the plate was incubated overnight at 37 ºC
humidified with 5% CO2. Then, two portions of 5 min EMEM PAM (1 ml each), as explained in
the PAM preparation method (Section II.2.2), were used to treat cells 10% HEPES solution was
added to the media in order to buffer the pH during imaging. Since, PAM created with lower
exposure time (4 min or below) did not induce a noticeable change in cell viability of MDCK cells
and very long exposure time such as 10 min PAM caused severe cell death, 5 min plasma exposure
was selected to provide PAM with a moderate intensity (refer to cell viability results of PAM
shown in Section IV.1). After the PAM application, a time-lapse microscopy of control and PAM
treated samples was started. The 24-well plate was fixed on an automated stage at a temperature
of 37 °C. Phase-contrast images were acquired at 10X magnification using an inverted microscope
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(DMi8, Leica Microsystems) equipped with a CCD camera (Andor Technology Ltd). Images were
captured every 10 min for a period of 48 h (288 images) after PAM addition. ImageJ software
(NIH) was used for the processing and analysis of the resulting images.

II.7

IMMUNOFLUORESCENCE

Immunofluorescence is a common method in biological and clinical research to visually and
quantitatively detect specific proteins in cultured cells and tissues. In this method, two antibodies
are used: primary and secondary antibodies. The primary antibody selectively attach to a specific
antigen and the secondary antibody which is conjugated to a fluorescent dye will attach to the
primary antibodies. Eventually, fluorescence microscopy leads to excitation and emission in the
fluorescence dyes and visualization of labeled cells.
For immunofluorescence experiments, 80,000 cells per well of MDCK cells were grown overnight
on a collagen coated (0.2 mg/ml col1) square coverslips which were placed in a 6-well plate. Cells
were then covered with 2 portions (1 ml each) of 5 min EMEM PAM in addition to 1 ml of the
fresh complete cell culture media and then placed in a humidified incubator with 5% CO2 for 48 h
at 37 oC. For the control samples, the older media were replaced by 3 ml of fresh complete cell
culture media. For conducting immunofluorescence, the media were discarded and coverslips were
washed with CB buffer (Cytoskeletal buffer: 10 mM MES, 3 mM MgCl2, 0.14 M KCl, pH 6.8).
This was followed by a 15 min incubation in a permeabilization/fixing solution containing 4%
paraformaldehyde, 1.5% BSA and 0.5% Triton in CB buffer at room temperature. Cells were then
washed three times with PBS, for 5 min each time. Samples were then incubated with an
appropriate dilution of each of the primary antibodies or 488-phalloidin for 1 h, followed by three
PBS washes and were again incubated for 1 h with the secondary antibodies. Following the first
PBS wash after the secondary antibodies incubation, cells were incubated in DAPI (4',6Diamidino-2-Phenylindole) diluted in PBS for 5 min. Each coverslip was mounted on a glass slide
and stored overnight at 4 °C prior to imaging. Fluorescence images of cells were acquired using
an epi-fluorescence microscope (DMi8, Leica Microsystems) equipped with a CCD camera
(Andor Technology Ltd) and 10X, 20X, and 40X objectives. All chemicals used for
immunofluorescence were from Fisher Scientific unless otherwise mentioned. The following
primary antibodies and their dilution were: beta-catenin (BD Biosciences, 1:100 dilution) to mark
cell-cell adhesions, paxillin (Santa Cruz Biotech, 1:100) to mark cell-surface adhesions and Ki-67
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(Dako, 1:150) to mark proliferating cell nuclei. Phalloidin-488 (Molecular Probes, 1:200) was used
to mark filamentous actin. The secondary antibodies used were (all from Jackson
ImmunoResearch) anti-mouse (1:200) and anti-rabbit (1:200) IgG.

II.8

STATISTICAL ANALYSES

Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS, IBM,
USA) software and results were analyzed using independent t-test or chi-square test. A p-value
below 0.05 was considered to be statistically significant (* p < 0.05), ** p < 0.01, *** p < 0.001).
In statistics, the p-value is the probability of observing a given sample results when the null
hypothesis is true.

II.9

SUMMARY

In this chapter, the low temperature plasma source (plasma pencil), cell lines, and cell culture
media used in this work were introduced. This was followed by a detailed presentation of all the
experimental methods and procedures including the various assays used in this research. SCaBER
cells with squamous cell carcinoma disease from a urinary bladder were used to evaluate the antitumor effects of LTP on epithelial cancerous cells. Cells were initially treated by direct plasma
exposure. Then, as an indirect treatment method, plasma activated media were examined. Trypan
blue exclusion assay and MTS assay were successfully employed to inspect cells viability after
treatment. Caspase-3 activation level in PAM-treated SCaBER cells was assessed to diagnose the
cell injury mechanism induced by plasma treatment. To assess damaging effects of LTP treatment
on DNA, a molecular beacon of DNA was treated by the plasma pencil and the extent of damage
was analyzed. Since, LTP-generated ROS are mainly responsible for the anti-tumor properties of
plasma, the concentration of hydrogen peroxide –as one of the most stable and impactful ROS- in
PAM was measured by means of a molecular probe (Amplex red kit). The temporal effectiveness
of PAM and the stability of hydrogen peroxide generated in PAM were analyzed. A normal/healthy
epithelial cell line, MDCK, was used to evaluate the effects of PAM on non-cancerous cells. Timelapse microscopy in addition to immunofluorescence was employed to gain further understanding
of PAM treatment effects on proliferation, morphology, and migration of normal cells.
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CHAPTER III
RESULTS AND DISCUSSION OF EXPERIMENTS AND TREATMENT OF
CANCER CELLS
III.1

EFFECTS OF PLASMA ON THE VIABILITY OF CANCER CELLS

III.1.1 Direct Treatment of Cancer Cells
SCaBER cells were treated with direct plasma exposure and the results are shown in Figure 9.
Trypan blue exclusion assay was used to count the number of live and dead cells at 0 h
(immediately after treatment), 12, and 24 h after the treatment. As it shows, the longer the exposure
time to plasma, the lower the number of survived cells. For instance, at 12 h post-treatment the
viability of cells reduced to around 50% for 2 min plasma treatment time while it reduced to more
than 80% for 3 min treatment time. It is also shown that 4 and 6 min plasma exposure led to more
than a log reduction in the viability of cells. Moreover, at longer post-plasma treatment times a
higher number of dead cells was observed, which is known as the delayed effect. LTP treatments
for 2 and 3 min diminished the viability of SCaBER cells to more than 70 and 90 percent after 24
h, respectively.
The measurement of cells viability immediately after LTP exposure is shown in Figure 10. This
figure shows that the number of live and dead cells did not change meaningfully in the control and
LTP treated samples. This result indicates that LTP treatment at different exposure time did not
induce immediate physical damage. In fact, the interaction between SCaBER cells and LTPgenerated reactive species requires a sufficient time to show an effect. It is of note to mention that
the result of LTP treatment on the viability of cells is highly dependent on the initial cell
concentration and this is the reason of the slight difference in the number of cells in Figure 10.
No changes were observed in the viability of SCaBER which were treated with only a flow of
helium gas without plasma. This result indicates that helium gas did not have a harmful effect on
cells during the LTP treatment.
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Figure 9. The Viability of SCaBER cells treated with direct plasma exposure shows the number of
dead and live cells. The viability was monitored at A) 12 and B) 24 h post-plasma treatment using
a trypan blue exclusion assay.
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Figure 10. The number of live and dead SCaBER cells assessed immediately after direct plasma
treatment.

III.1.2 PAM Treatment of Cancer Cells
As presented in the previous chapter, plasma activated media (PAM) is an indirect way to submit
cancer cells to plasma exposure. In this protocol, adhered cells were treated with PAM which was
produced by the exposure of cell culture media to the plasma pencil at a designated exposure time.
Figure 11 shows the effect PAM treatment on SCaBER cells when used immediately after
preparation. Let’s call it immediate-PAM to differentiate it from aged-PAM. In this experiment,
liquid media was exposed to plasma for 2, 3, and 4 min while 0 min represents the control,
untreated media. The MTS assay was used to evaluate the number of metabolically active cells at
12, 24, and 48 h post-PAM application. The percentage of metabolically active cells was calculated
by normalizing the number of cells in PAM treated samples to the control at each measurement
time. During treatment time, cells were covered by PAM for the entire time. As can be seen in
Figure 11, the viability of cells decreases with increasing the PAM exposure time. The metabolic
activity of cells treated with 2 min PAM reduced to more than 80% at 12 h post-PAM treatment.
3 and 4 min PAM induced a log reduction in the cell viability. No significant changes were
observed in the percentage of cells viability of 3 and 4 min PAM at the delayed measurement times
of 24 and 48 h while, this is not the case in 2 min PAM. For 2 min PAM, the percent of viable

30
cells was around 13, 30, and 55% at 12, 24, and 48 h, respectively. This increase in the percentage
of viable cells indicates that the effectiveness of 2 min PAM reduces over the delayed measurement
times. It appears that cells gradually recovered from the induced oxidative stress at 24 and 48 h of
PAM application.
Results of both PAM treatment and direct treatment reveal the capability of plasma-based
treatment in inducing cell death in cancerous SCaBER cells. In addition, the anti-cancer properties
of plasma-based treatment is related to the amount of plasma exposure time. Since it is known that
RONS play the major role in the anti-cancer properties of plasma-based treatment, it can be
expected that increasing the plasma exposure time increases the concentration of LTP-generated
ROS and RNS which enhances the anti-cancer properties of plasma-based treatment. Measurement
of the concentration of hydrogen peroxide in PAM will be presented and discussed later in this
chapter as it will help better understanding of the role of ROS in the LTP cancer treatment.
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Figure 11. The effect of PAM produced by different exposure time on the viability of SCaBER
cells using MTS assay. Metabolic activity of cells was measured at 12, 24, and 48 h post-PAM
treatment. Results from 3 independent experiments with two replications are shown as means ±
SD (standard deviation) [88].

31
Effects of aged-PAM on SCaBER cells viability
Stored or aged-PAM was used to investigate how long PAM remains effective against cancer cells
after its preparation. It is proposed that the concentration and lifetime of reactive species induced
in PAM determine the shelf life of PAM. In this procedure, PAM was stored for 1, 8, and 12 h
before the application.
Figure 12 indicates the effects of PAM with different aging times on the viability of SCaBER cells.
The percentage of viable cells was measured at 12 h after PAM treatment using MTS assay. This
result indicates that PAM efficiency decreases with increasing aging time. However, reduction in
the efficiency of PAM is more remarkable at shorter exposure times such as 2 min. Although, at
longer exposure time (such as 4 min) PAM remained highly effective against SCaBER cells even
after 12 h aging. Aging the 2 min PAM for 1 h caused only ~ 8% reduction in its efficiency while,
aging for 8 and 12 h led to around 48% and 83% efficiency reduction, respectively. Aging the 3
min PAM up to 8 h did not change its efficiency whereas, 12 h aging resulted in 17% reduction in
the efficiency. On the other hand, no significant reduction was observed in the efficiency of 4 min
PAM even after 12 h aging. Based on these data, the shelf life of PAM (stored at room temperature)
is dependent on the duration of plasma exposure time. Accordingly, the concentration of LTPgenerated RONS in PAM is higher at longer exposure time and therefore PAM requires a longer
aging time to lose its anti-cancer efficacy.
To demonstrate changes in viability of cells treated with aged-PAM, MTS assay was utilized at
12, 24, and 48 h post-PAM treatment. Error! Reference source not found. 13 A, B, and C show
results of the MTS assay for 1, 8, and 12 h aged-PAM, respectively. As can be seen, the percentage
of cell viability is approximately the same in all aged-PAM which indicates that there was not a
delayed effect in results of aged-PAM at 12, 24, and 48 h post-PAM application. As it was
mentioned earlier once PAM was added to each well, cells were exposed to it the entire time of
treatment up to the time of cell viability assay, which means either 12, 24, or 48 h.
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Figure 12. Effectiveness of immediate PAM and aged-PAM to induce cell death in SCaBER cells
when stored for 1, 8, and 12 h before utilizing. Metabolic activity of cells was measured at 12 h
post-PAM application. Cells were exposed to PAM the entire 12 h of treatment. Results are shown
as means ± SD from 3 independent experiments with two samples replications.
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Figure 13. Percentage of metabolically active SCaBER cells treated with aged-PAM at 12, 24, and
48 h post aged-PAM treatment. PAM was aged at room temperature for A) 1 h, B) 8 h, and C) 12
h before application. Results are shown as means ± SD from 3 independent experiments with two
samples replications.
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Figure 13. (Continued).
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III.1.3 Effects of aliquoted PAM on SCaBER cells viability
It was observed that PAM treatment has a dose-dependent cytotoxic effect which was measured at
different plasma exposure times as was shown in Figure 11. It is expected that diluting PAM with
non-treated media may reduce the concentration of LTP-generated reactive species and the
effectiveness of PAM against cells, similar to the influence of plasma exposure time. To evaluate
the validity of this hypothesis, effects of aliquoted PAM on SCaBER cells viability was measured.
Results of aliquoted PAM on cell viability of SCaBER cells at 12 and 24 h post-treatment time are
shown in Figure 14. SCaBER cells were treated with a 4 min PAM diluted with fresh media with
the following ratio: 1:8, 1:4, 1:2, and 1:1; C is the control sample and 1:1 is 4 min PAM (no
dilution). Cell viability was measured A) 12 h and B) 24 h after treatment using MTS assay. Data
are mean ± SD from three independent experiments. A and B. In this experiment, 4 min PAM was
diluted with fresh media and cell viability was measured at 12 and 24 h post-PAM application
using MTS assay. As Figure 14. SCaBER cells were treated with a 4 min PAM diluted with fresh
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media with the following ratio: 1:8, 1:4, 1:2, and 1:1; C is the control sample and 1:1 is 4 min
PAM (no dilution). Cell viability was measured A) 12 h and B) 24 h after treatment using MTS
assay. Data are mean ± SD from three independent experiments. A and B indicate, 1:1 dilution
which is a pure 4 min PAM was the most effective PAM against cells viability. Consequently, the
effectiveness of aliquoted PAM decreased by increasing the dilution ratio (1:2 and 1:4). In the case
of 1:8 dilution, a minor growth was observed in the percent of
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Figure 14. SCaBER cells were treated with a 4 min PAM diluted with fresh media with the
following ratio: 1:8, 1:4, 1:2, and 1:1; C is the control sample and 1:1 is 4 min PAM (no dilution).
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Cell viability was measured A) 12 h and B) 24 h after treatment using MTS assay. Data are mean
± SD from three independent experiments.

metabolically active cells (around 5%). Again, no delayed effect was observed in the MTS result
of aliquoted PAM at 12 and 24 h after treatment. As a result, it is assumed that decreasing the
portion of PAM in an aliquoted solution resulted in a decrease in ROS levels and ultimately a
reduction in the effectiveness of treatment against SCaBER cells.
To provide a better understanding of the characteristics of an aliquoted PAM, it is assumed that
dilution ratio has a somewhat similar function as the plasma exposure time. For instance, it is
expected that 1:2 dilution of 4 min PAM would be equivalent (have similar killing effect) to a 2
min PAM. Based on this assumption, in Figure 14A and B 1:2 dilution of 4 min PAM will be
shown as 2 min plasma exposure time. Respectively, 1:4 and 1:8 dilution ratio is equivalent to 1
min and 30 s plasma exposure time. To examine our assumption, results of the aliquoted PAM
from Figure 14. SCaBER cells were treated with a 4 min PAM diluted with fresh media with the
following ratio: 1:8, 1:4, 1:2, and 1:1; C is the control sample and 1:1 is 4 min PAM (no dilution).
Cell viability was measured A) 12 h and B) 24 h after treatment using MTS assay. Data are mean
± SD from three independent experiments. will be shown as a function of the exposure time and
will be compared with the result of immediate PAM (from Figure 11). This comparison is shown
in Figure 15A and B. Interestingly, one can see that the trend of both graphs is very similar, which
indicates that there is a correlation between the dilution ratio and the time of plasma exposure.
Consequently, the effectiveness of PAM against SCaBER cells can be modulated by a dilution
other than the exposure time.
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Figure 15. Comparison between the effectiveness of immediate PAM and diluted 4 min PAM on
the viability of SCaBER cells assessed at A) 12 h and B) 24 h post-PAM application. The dilution
ratio in aliquoted PAM was converted to the plasma exposure time: 30 s (1:8), 1 min (1:4), 2 min
(1:2), and 4 min (1:1).

38
III.1.4 SCaBER Cells Treated with Staurosporine
To measure the potency of PAM against cancer cells, a comparison between the efficacy of PAM
and staurosporine, an apoptosis-inducing drug, was conducted. Figure 16 shows the number of live
cells treated with 1 ml of 4 min PAM and 1 µM staurosporine in a 24-well plate after 10 and 24 h
using trypan blue exclusion assay. It is clear that 4 min PAM is at least as effective as staurosporine
in killing the SCaBER cells. In fact, PAM outperforms staurosporine by killing an order of
magnitude higher number of cells at 10 h post treatment while both seem to have a similar effect
for longer times. The number of live cells indicates that 4 min PAM applied for 10 h over SCaBER
cells has an efficiency equivalent to 1 µM staurosporine applied for 24 h.

Figure 16. Staurosporine vs. PAM treatment. SCaBER cells were incubated by 1 µM staurosporine
and 4 min PAM and cells viability counted at 10 h and 24 h after treatment using the trypan blue
exclusion assay [89].
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III.2

CONCENTRATION OF HYDROGEN PEROXIDE IN PAM

Hydrogen peroxide is an important ROS by being able to penetrate the cell membrane. It
intermediates in many reactions and results in more ROS production such as OH• although, it is
not a radical species [59]. The concentration of H2O2 was measured in MEM PAM and in serumfree PAM immediately after PAM preparation and over times after aging (see Figure 17). The
Amplex red measurements indicate the presence of hydrogen peroxide in PAM in an exposure
time-dependent manner. As can be seen in Figure 17A, the concentration of H2O2 increases in
PAM by increasing the plasma exposure time. 2 and 4 min PAM contained around 130 and 350
µM of hydrogen peroxide, respectively.
It was found that H2O2 degrades in PAM over time. The longer the aging time, the lower the
concentration of H2O2. For instance, H2O2 concentration in 2 min PAM reduces by 18%, 45%, and
80% after 1, 8, and 12 h aging, respectively. Interestingly, it was observed that the effectiveness
of PAM against SCaBER cells reduces as a function of aging time. Looking at the results of 2 min
PAM efficiency in Figure 12 and at the level of H2O2 for different aging times in Figure 17A
indicates that both killing efficiency and H2O2 concentration follow a similar reduction trend. The
correlation between the efficiency of PAM and the H2O2 level for different aging times manifests
the important role of hydrogen peroxide in the anti-cancer effect of PAM. Similar to the 2 min
PAM, aging led to H2O2 concentration reduction in 4 and 6 min PAM. In 4 min PAM, H2O2
concentration reduces by around 15%, 40%, and 72% after 1, 8, and 12 h aging, respectively.
However, in the case of 4 min PAM, the level of ROS concentration was still above a tolerable
level for SCaBER cells even after 12 h aging. Although H2O2 concentration was reduced by around
70% at 12 h after aging, its toxicity level was still drastically high for SCaBER cells as it caused a
log reduction in cells viability.
Figure 17B presents H2O2 concentration in a serum-free PAM after 8 h aging. The level of H2O2
is approximately 2 times higher in a serum-free PAM than in PAM containing serum (Figure 17A),
depending on the plasma exposure time. At a longer exposure time, such as 6 min PAM,
differences between the two concentrations is a bit lower which reveals the limited scavenging
capacity of the serum. According to the Fenton reaction which was proposed by Haber and Weiss
[90]:
Fe2+ + H2O2 → Fe3+ + OH• + OH ̶
•

•

OH + H2O2 → HO2 + H2O,

(3)
(4)
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H2O2 reduces into OH• and HO2• (hydroperoxyl radical) in the presence of Cu2+ or Fe2+ ions.
Serum added in a cell culture media contains metallic compounds like ferrous ions. As it is
expected presence of it in PAM scavenged the LTP-generated hydrogen peroxide. This result
specifies the importance of chemical formulation of media in modulating the concentrations of
ROS and determining the stability of PAM.
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Figure 17. A) Concentration of H2O2 versus plasma exposure time measured in MEM immediately
after plasma exposure and 1, 8, and 12 h after aging. B) H2O2 concentration in a serum-free PAM
was measured after 8 h aging. Data represent the mean ± SD of three independent experiments.
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EMEM PAM was used to treat MDCK normal cells and the H2O2 concentration in it was measured
immediately after plasma exposure as shown in Figure 18. This result indicates that the level of
H2O2 in EMEM PAM (including serum) is proportional to the exposure time, similar to MEM
PAM. The goal of this experiment was to examine how the slight difference between the chemical
compositions of these two media is important in their subsequential effect on cells viability.
Comparing the result of Figure 18 with the one of immediate MEM PAM showed in Figure 17A
reveals that the H2O2 concentration (µM) is in the same order of magnitude in both types of PAM.
This outcome supports our assumption and indicates that the minor differences in EMEM and
MEM chemical formula have a negligible impact on the cell viability results.
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Figure 18. H2O2 concentration was measured in EMEM PAM immediately after plasma exposure.
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III.3

RESULTS OF CASPASE-3 ACTIVITY IN PAM TREATED SCaBER

CELLS
Caspase-3 is a widely used indicator of apoptosis. Caspase-3 is a member of caspases family and
is considered to be the most important executioner among other caspases [91]. In order to
understand the mechanism of cell injury in plasma treated SCaBER cells, the caspase-3 activity
was investigated using ApoAlert1 Caspase Colorimetric Assay Kit (Clontech Laboratories, Inc.).
Figure 19A and B shows the level of caspase-3 measured in SCaBER cells treated by 2 min PAM
and staurosporine. Caspase-3 is an early apoptosis inducer [92] therefore cells morphology and
activity measurements were conducted at short time after PAM treatments. In staurosporine treated
samples, morphology of cells began changing drastically after 6 h and most of cells were dead by
10 h. Hence, caspase-3 measurement was conducted at 4 and 6 h after staurosporine treatment.
Likewise, the measurement in 2 min PAM treated cells was conducted up to 10 h post-PAM
application before widespread cells death. As can be seen in Figure 19B, the magnitude of
absorbance in the PAM treated samples does not show a meaningful elevation in the caspase-3
activity compared to the control. The highest level of caspase-3 in PAM treated samples was
measured at 6 h, with around 1.5-fold increase. The highest level of caspase-3 activity was detected
in staurosporine treated cells at 6 h after treatment with around 4-fold increase in comparison with
the control. These outcomes suggest that cell injury pathway induced by PAM treatment could be
a caspase-independent apoptosis or a necrotic cell death.
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Figure 19. Level of caspase-3 in A) 2 min PAM treated SCaBER cells and B) staurosporine treated
cells which was measured at various times after treatment using Apoalert kit. Absorbance (a.u.)
was measured at 405 nm in both control and treated samples.

Caspase inhibitors are used to explore the overall roles of proteases in an apoptotic process.
Synthetic tetrapeptides DEVD-CHO and DEVD-fmk are examples of caspase-3 inhibitors in
which the first one is a reversible inhibitor and the latter is irreversible [93]. In another experiment,
caspase-3 inhibitor was used to validate (examine) the result achieved by caspase-3 assay kit. This
inhibitor blocks apoptosis through caspase-3 activation. For this purpose, SCaBER cells cultured
in a 96-well plate were incubated with DEVD-fmk 100 µM for 30 min prior to any treatment.
Then, the inhibitor solution was discarded and cells were either treated with 2 and 4 min PAM or
were treated with only fresh media (negative control). As a positive control, SCaBER cells sample
did not receive any DEVD-fmk inhibitor incubation and were treated with PAM as before. Cell
viability was assessed at 8 and 12 h post-PAM application using MTS assay. Cells morphology
was monitored using bright-field microscopy.
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After addition of caspase-3 inhibitor, it was observed that the morphology of cells was changed
and cell-surface attachment was gradually diminished (see Figure 20A). However, non-PAM
treated cells (negative control) recovered their normal morphology after removal of inhibitor
solution (see Figure 20B).
Figure 21 are images of PAM treated SCaBER cells after 12 h in two conditions: with and without
DEVD-fmk incubation. The bright-field images, as shown in Figure 21A-D, indicate that samples
underwent similar morphological changes independent of the inhibitor addition. Besides, MTS
assay results supported the morphological observations and indicated that cells viability results
were similar in both conditions in 2 and 4 min PAM treated samples Figure 22 shows the result of
MTS assay measured at 12 h post-PAM application in samples pre-incubated with DEVD-fmk
inhibitor (shaded bars) versus samples not incubated with the inhibitor (blank bars). There is not a
meaningful difference between two groups indicating that PAM treatment suppressed cell viability
of both groups in a similar trend. According to this result, caspase-3 inhibitor could not prevent
cell death induced by PAM treatment. This failure in blocking cell death indicates that PAM
treatment induces caspase-independent cell death in SCaBER cells. The mechanism of cell death
could be via mitochondrial-mediated, lysosomal membrane permeabilization, or necrotic cell
death.
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A

B

Figure 20. SCaBER cells were incubated with 100 µM DEVD-fmk (caspase-3 inhibitor) for 30
min. Image of cells taken at A) 45 min and B) 12 h after incubation. After addition of DEVD-fmk,
cell-surface attachment was gradually diminished (A); however, cells recovered their normal and
spread morphology after removal of the inhibitor solution (B).
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Figure 21. Images of SCaBER cells at 12 h of PAM treatment. A) and B): 2 min PAM treatment
with and without prior incubation with 100 µM DEVD-fmk, respectively. C) and D): 4 min PAM
treatment with and without prior incubation with 100 µM DEVD-fmk, respectively. Cells
morphology and damages in both groups with and without inhibitor incubation are similar which
indicate that PAM treatment induces similar effect on SCaBER cells independent of the DEVDfmk inhibitor addition. The MTS assay result supported these observations.
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Figure 22. The percentage of the metabolically active cells at 12 h after PAM application using
MTS assay. Shaded bars are cells pre-incubated with DEVD-fmk inhibitor and black bars are
samples not incubated with the inhibitor. Since there is not a meaningful difference between cell
viability of these two groups and caspase-3 inhibitor did not prevent cell death induced by PAM
treatment, it is concluded that the mechanism of cell death was caspase independent.

III.4

EFFECTS OF PLASMA ON REATTACHMENT OF SCABER CELLS

The time evolution of SCaBER cells attachment was monitored after direct plasma treatment and
are shown in Figure 23. The cells were treated with the plasma pencil after seeding and before
cells started to attach to the surface of the plate. Round-shaped cells remain in suspension and are
not actively attaching to the bottom of the cell culture plate. However, after reattachment the
morphology of cells turn into a spread shape. As can be seen in Figure 23, all the cells were in
suspension at zero hour (right after plasma treatment). At later times, cells started attaching to the
surface of the plate. As shown in Figure 23A, at 1.5 h after seeding cells in the control sample
started to attach to the surface (around 50% of the cells were attached) and cell morphology
exhibits a spread shape. However, for the 2 min treated sample the attachment of cells initiated
after 3 h (see Figure 23B). For the case of 5 min treated sample, most cells remained in rounded
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morphology up to 4.5 h after seeding (Figure 23C) which indicates the attachment process
experiences a longer delay. These observations suggested that plasma exposure induces an
alteration in cell membrane characteristic resulting in a delay in the attachment of the SCaBER
cells to the surface of the plate depending on the plasma exposure time. Results of this experiment
were published in [94].
Immunofluorescence experiments – following the method discussed earlier in Section II.7 – was
used to determine if any adverse effects on the actin of SCaBER cells was detectable. Actin is
made of a group of proteins which polymerizes to form actin filaments in the cytoskeleton of
eukaryotic cells. SCaBER cells were treated by 2 min PAM and immunofluorescence was
conducted 4 h after PAM application. Images from immunofluorescence assay of control and PAM
treated samples are shown in Figure 24. The overall filamentous actin organization in the control
and PAM treated samples did not differ significantly.
Other investigations reported that plasma treatment affects cell attachment, similar to our
observations. It was shown that a miniature plasma jet detached cells from the surface of a cell
culture plate [32]. Detached cells remained metabolically active as they were able to adhere to a
surface and grow successfully after transplanting to a new plate. Similar results were reported for
non-small cells lung cancer (NSCLC) [29]. According to this research, cell detachment occurred
at the area of the direct impact of the plasma needle even after a short exposure time but detached
cells that remained alive could reattach to the surface. Also, the presence of a thin layer of culture
media inhibited the cell detachment. They concluded that cell detachment by the plasma needle
was the result of a physical process on the cells [30].
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Figure 23. Images of SCaBER cells attaching to the surface of a culture plate at different times
after seeding. Photos were taken at specific times as noted on each image. Panel A) is the control
SCaBER cells, panel B) is a 2 min LTP treatment, and panel C) is a 5 min LTP treatment [94].
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Figure 23. (Continued).
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Figure 24. Images of fluorescence immunostaining of actin filaments in SCaBER cells A) control
and B) PAM treated sample. SCaBER cells were treated by 2 min PAM and immunofluorescence
was conducted 4 h after PAM treatment. This result shows that PAM treatment did not cause any
damages or adverse effects on the actin filaments of SCaBER cells as the immunostaining images
of control and PAM are similar. Scale bar of 50 µm at 40X magnification.
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III.5

SUMMARY

In this chapter, effects of LTP treatment on epithelial cells were investigated and results of
experiments were represented and discussed. The first part showed the effects of direct and PAM
treatment on the viability of SCaBER cells. It was observed that the viability of cells decreases by
increasing the plasma exposure time. It was also reported that diluted PAM has an equivalent effect
on cells viability as the plasma exposure time. Results of aged-PAM on SCaBER cells were shown.
It was found that the efficiency of PAM against SCaBER cells decreases over time. This reduction
in the efficiency of PAM was more remarkable at shorter plasma exposure time since, longer
plasma-exposed PAM remained highly effective.
Measuring the concentration of H2O2 in PAM confirms the important role of ROS in the anticancer properties of PAM. The concentration of H2O2 was moderately high in PAM when
measured right after plasma exposure. However, its concentration gradually dropped over time. It
was shown that there is a similar trend between the reduction of PAM efficiency and the decrease
in H2O2 concentration. This correlation supports the hypothesis that LTP treatment instigates
oxidative stress in cells and the dose of LTP-generated ROS determines the fatal effects of the
treatment. Furthermore, it was shown that LTP treatment results in DNA damage by manifesting
rapture in a treated molecular beacon. Mechanism of cell injury was evaluated in PAM treated
SCaBER cells by analyzing caspase-3 activity. The outcome of this experiment suggested that the
cell death is through caspase-independent pathways.
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CHAPTER IV
RESULTS OF PAM TREATMENT ON NORMAL CELLS
IV.1

PAM TREATMENT OF NORMAL CELLS

One of the important aspects of a cancer treatment method is to have minimum killing or side
effects on normal cells in the tissue surrounding a tumor. Therefore, it is important to understand
how plasma treatment affects normal healthy cells. Effects of PAM treatment was assessed on
normal epithelial cells from a canine kidney tissue (MDCK) and the results are shown in Figure
25. Figure 25Error! Reference source not found.A shows the percentage of the metabolically
active cells analyzed at 12, 24, and 48 h post-PAM applications. Cells were exposed to PAM the
entire time of treatment prior to MTS assay which was 12, 24, and 48 h. These results indicated
no significant changes in the viability of MDCK cells up to 3 min PAM. Using 4 min and 6 min
PAM induced around 10% and 20% reduction in metabolic activity of normal cells after 12 h,
respectively. However, PAM created with a longer exposure time (10 min PAM) resulted in one
log reduction in the metabolic activity of cells. As seen in Figure 25Error! Reference source not
found.A, there was no delayed effect of PAM (12, 24, and 48 h of PAM treatment resulted in
equivalent kill ratio).
For a better interpretation of MDCK response to PAM treatment, the raw data of cell viability
(cells/ml) are shown in Figure 25Error! Reference source not found.B. The number of viable
cells was quantified with MTS and trypan blue exclusion assays. The black column (initial cell
concentration) represents the number of cells at the time of PAM application. As can be seen in
Error! Reference source not found.B, within the 48 h of monitoring, the number of live cells
grew in the control as well as in samples treated by PAM that was created with a lower exposure
time. In the case of 10 min PAM, the number of metabolically active cells was lower than the
initial cell concentration which clearly reveals widespread cell death. In PAM samples up to 3 min,
the trend of cell proliferation is similar to the control; however, cells growth in 4 and 6 min PAM
was decreased slightly. This reduction in cells growth (lower number of live cells) can be due to
an inhibition of cell proliferation. Results of further experiments supported this observation which
will be discussed under the time-lapse microscopy and immunofluorescence results. Therefore, it
was concluded that the dose of plasma exposure is highly consequential in determining the harmful
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effect of PAM on normal cells. PAM with a moderate intensity (i.e. moderate exposure time) can
affect cells proliferation while, a highly
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Figure 25. Effect of PAM produced by different exposure times on the viability of non-cancerous
MDCK cells using MTS assay and trypan blue exclusion assay at 12, 24, and 48 h post-PAM
treatment: A) Percent of cell viability normalized to the control and B) number of metabolically
active cells (cells/ml). Initial concentration represents the number of cells at the time of PAM
treatment. Results from 3 independent experiments with two replications are shown as means ±
SD.
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plasma activated medium (i.e. longer exposure time such as 10 min PAM) can induce significant
cell death in normal cells.
Figure 26 shows the response of SCaBER and MDCK cells to PAM treatment at 12 h post-PAM
application. As it clearly shows, SCaBER cells were considerably more susceptible to PAM
treatment than MDCK cells. For instance, a 4 min PAM induced more than 90% reduction in the
viability of SCaBER cells in contrast to MDCK cells which underwent only 10% reduction. This
clearly reveals that, unlike the case of SCaBER, PAM treatment does not have severe damaging
effects on normal MDCK cells at exposure time below 4 min.
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Figure 26. Cell viability of SCaBER and MDCK cells treated by PAM with different exposure
times measured 12 h post PAM application.

57
As it is mentioned earlier, it is important that a therapeutic method has no or a minimum impact
on normal cells and surrounding tissues of a treated tumor hence, an ideal method will selectively
target cancer cells without harming normal cells. This reflects the selective effect of a treatment
method. Other research groups investigated the response of cancer and normal cells to LTPtreatment and reported similar results in that, cancer cells were more susceptible to the LTP
treatment than normal cells, depending on the cell type [33, 37, 50, 95, 96].
Iseki et al. used two independent ovarian cancer and normal fibroblast cells to evaluate the
selective effect of plasma on cells viability and proliferation. They reported that direct plasma
treatment was effective to kill cancer cells while normal fibroblast cells were mostly undamaged
[97]. In another study, Kim et al. [98] showed that cancer cells were more influenced by the direct
plasma treatment than normal cells although both cell types were under an NO-mediated oxidation.
They measured NO concentration in normal and cancer cells and reported that the level of NO was
lower in the normal cells (foreskin fibroblast and bronchial epithelial) than the cancerous type
(lung adenocarcinoma cells). In addition, they reported that the concentration of NO2− was higher
in cancer cells compared to the normal cells. NO2− and NO3− are the by-products of NO and are
used as convenient markers of NO [99]. As mentioned earlier, NO has cytotoxic effects such as
reactions with proteins and nucleic acids plus induction of NO-mediated apoptosis [98]. In another
work, Guerrero-Preston and colleagues [96] showed that direct LTP treatment selectively killed
the HNSCC (head and neck squamous cell carcinoma) cells with a non-apoptotic mechanism while
minimally affected normal oral cavity epithelial cells.
The answer to the question of why cancer cells are more susceptible to LTP treatment than normal
cells lays to the characteristic differences of these cells that originated from their metabolism. A
low concentration of ROS are beneficial for cells and have an important role in regulating cell
signaling pathways and affects cellular processes such as metabolism, proliferation,
differentiation, and survival processes like apoptosis, antioxidant response, and DNA damage
response [42, 57, 74]. NADPH (nicotinamide adenine dinucleotide phosphate) and NOX (NADPH
oxidase) are involved in the production of a low level of ROS via an oxidation-reduction (also
known as redox) process [100]. A moderate level of ROS activates stress-responsive genes such
as HIF1Α (Hypoxia-inducible factor 1-alpha) which, in turns, leads to the expression of proteins
that modulate pro-survival signals in cells [101]. Ultimately, a high dose of ROS creates
irreversible havoc in cells by causing damages to macromolecules and DNA, resulting in
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apoptosis. Under these conditions, antioxidant molecules act as a cell defense system to defeat
ROS damage by reducing excessive level of ROS such as reduced GsH (glutathione) and TrX
(trithorax) [101].
Metabolic activity of cancer cells is different from normal cells. In fact, tumor cells set up
mutations in their metabolic activities in order to support their abnormal growth and survival.
Following are three basic requirements for dividing cancer cells which need to be modified:
generating ATP faster to sustain the energy level in a tumor cell, enhancing biosynthesis of
macromolecules, and increasing the maintenance of intracellular redox to keep it at an appropriate
level [101]. Therefore, these alterations result in a high ROS production and a high antioxidant
level in cancerous cells.
Figure 27 is a schematic that indicates how the ROS level relates to cells viability. As it was
explained earlier, lower level (yellow) of ROS is beneficial in cell proliferation and survival.
However, excessively high level (purple) of ROS causes detrimental oxidations that can result in
cell death. The antioxidant system protects cells from such oxidative damages by reducing ROS
from a high accumulated level. In a cancer cell, abnormal metabolism and protein translation
generate irregular high levels of ROS. The mutations and adaptations in a cancer cell allow cells
to avoid the detrimental effects of high ROS levels by regulating antioxidants and ROS in such a
way that the cell survives in a moderate level of oxidative stress (blue).
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Figure 27. Reprinted by permission from Nature Publishing Group: Cairns et al [101]. Low
levels of ROS in helping cell survival and proliferation while, high ROS levels cause detrimental
damages. Cancer cells encounter an abnormally high oxidative stress and adapt to survive this
condition by expressing more antioxidants to maintain a moderate level of ROS.
Because of the abnormal high level of ROS in cancer cells, they are more susceptible to a redox
increment than normal cells. [1]. Therefore, one can regulate a dose of oxidative stress which
causes an irreversible damage to cancer cells while normal cells survive under such a dose. Since
the ROS levels in cancer cells are abnormally high, an induction of redox stress may push the level
of ROS above an acceptable threshold and results in cell death. However, normal cells with their
lower basal ROS level and higher antioxidant capacities can better survive the oxidative stress [1].
Consequently, the difference between intracellular ROS level in cancer and normal cells is one
way to explain the selective effect of plasma. Figure 28 illustrates the basic idea behind the
selective effect of redox stress.

Figure 28. Reprinted by permission from Nature Publishing Group: Trachootham et al. [102].
Illustration of the base level of ROS in normal and cancer cells. An enhanced ROS stress pushes
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the intracellular ROS which in the case of cancer cells may exceed the survival threshold and
results in detrimental cell damages or cell death.

IV.2

TIME-LAPSE IMAGING OF MDCK CELLS

In order to ascertain the effect of moderate PAM treatment on MDCK cell morphology,
proliferation, and migration in PAM and control samples, time-lapse phase imaging of the cells
was carried out. As the result of MTS assay of MDCK cells in Figure 25B indicates, PAM
treatment with moderate intensity affects cells proliferation rather than inducing widespread cell
death. In this experiment, phase images of cells were taken every 10 min and continued up to 48
h after PAM addition. Figure 29A and B show images of control and PAM treated samples
acquired at various time points. These images are selected from movies that are provided as online
supplementary material. Figure 29A and Supplementary Movie 1 of a control sample demonstrate
a rapid proliferation in cells over 48 h. In contrast, cells in the PAM treated sample did not show
a similar increase in population number which is visually clear in Figure 29B and in the
Supplementary Movie 2 of the PAM sample. Nevertheless, no major physical cell damage or
shrinkage were observed in the time-lapse movies. These data support the results from the impact
of moderate PAM on MDCK cells obtained by MTS assay.
The reduction in the number of live MDCK cells at the 48 hour time point in the PAM treated
sample (compared to the control case) could be the net result of a combination of an increase in
the rate of cell death and an inhibition of cell proliferation. To delineate the relative contributions
of these factors, the number of dividing cells in the time-lapse sequence was manually counted
using the ImageJ software and was normalized to the total number of cells at 0 h. Figure 30 shows
an example of a dividing cell in a time-lapse sequence. During mitosis, the cell temporary rounds
up, divides into two and the daughter cells re-spread onto the surface [103]. Such cell division
events can be clearly seen in our phase time-lapse sequences, as shown in Figure 30: the cell
morphology changes from being spread to round (associated with higher brightness in the
periphery) indicating a loss of peripheral focal adhesions. After cell division, daughter cells spread
back to recoup their interphase morphology (Figure 30).
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A

Figure 29. Phase contrast images of A) control and B) PAM treated MDCK cells obtained by timelapse microscopy at different hours for a duration of 48 h. Cells in the control sample multiplied
during the 48 h of time-lapse imaging and cell islands were expanded while, the number of cells
in the PAM treated sample did not increase in population likewise. Nevertheless, no major physical
cell damage or shrinkage are observable in theses time-lapse images. These data suggest that a
moderate PAM affect proliferation of MDCK cells. Scale bar: 200 µm.
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Figure 29. (Continued).
B
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Figure 30. Phase-contrast images obtained from time-lapse imaging (of control sample) show
reshaping of a dividing cell (arrow) which adopts a round morphology from a spread shape and
the daughter cells then re-spread after cell division. White arrows show a cell going through cell
division process and is divided into two daughter cells. Time is indicated in hour:min. Scale bar
of 100 µm.

Figure 31 shows the number of division events normalized by the initial number of cells in the
control and PAM samples. The numbers of dividing cells were counted in each movie acquired
from 48 h of time-lapse imaging. According to these data, the number of dividing events (cell
division) decreased by around 75% in PAM treated sample. This result indicates that cell
proliferation was significantly reduced in PAM treated cells (p < 0.001) and suggests that
mitigation in the cell growth was associated with cell proliferation inhibition rather than
widespread cell death.
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Figure 31. Number of division events normalized by initial number of cells in control and PAM as
quantified from time-lapse images during 48 h of PAM treatment. Data represent averages from 6
movies from two independent experiments as means ± SD. An independent t-test indicates that
cell proliferation was significantly lower in PAM treated samples (mean = 1.97, SD= 0.28) than
control (mean = 0.40, SD= 0.32), t(10) = 8.987, *** P<0.001.

IV.3

INHIBITION OF PROLIFERATION OF MDCK CELLS

In order to confirm the inhibition of cell proliferation induced by PAM, the nuclear localization of
Ki-67, a marker of cell proliferation, was ascertained using immunofluorescence. Ki-67 is a protein
that is present in all active phases of a cell cycle including G1 (growth and metabolism phase), S
(DNA replication phase), G2 (growth of structural elements and preparation for mitosis), and M
(mitosis or cell division). However, Ki-67 is absent in the G0 (resting cells) phase [104]. That is
why the expression of human Ki-67 protein is associated with cell proliferation activity. Therefore,
it is an excellent marker for determining the “growth fraction” of both normal and tumor cells and
antibodies against Ki-67 protein are used to mark and diagnose proliferative cells [105]. Figure
32A shows immunofluorescence images from control and PAM treated MDCK cells in which Ki67 has been stained. Ki-67 staining is markedly brighter in cells that are actively involved in
proliferation. The number of Ki-67 stained cells were counted in at least 8 immunofluorescence
images obtained with 10x magnification from PAM and control samples. Figure 32B shows the
percent of Ki-67 stained cells, on average, in immunofluorescence images. As shown, the number
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of Ki-67 stained cells is lower in PAM treated cells than in the control which indicates inhibition
of proliferation. A chi-square test indicated a significant association between treatment and number
of marked cells, 𝑥 # 1 = 20.53, 𝑝 < 0.05. In fact, the percentage of stained cells in the control
sample was 1.7 times higher than that for the PAM treated cells with a 95% confidence interval of
(1.34, 2.11). This result supports the lower rate of cell proliferation in PAM samples as observed
using time-lapse imaging and the lower rate of cell division as shown in Figure 31.
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Figure 32. A) Immunofluorescence images of a control (right) and a PAM treated (left) sample.
Nuclei are stained with DAPI to visualize cells. Cells with higher brightness are stained with Ki67. B) The average percentage of Ki-67 stained cells in immunofluorescence images in PAM and
control sample. PAM treatment inhibits ki-67 and arrests cell proliferation in MDCK cells. Data
represent averages from at least 8 images from of two independent experiments as means ± SD. *
P<0.05 (chi-square test).
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IV.4

EFFECT OF PAM TREATMENT ON CELL MIGRATION

Time-lapse movies of MDCK cells upon PAM treatment also suggested that PAM treatment may
have affected random migration of cells within MDCK islands. To test this quantitatively, single
cells within the MDCK islands were tracked in the control and PAM time-lapse sequences using
MtrackJ (ImageJ software) and the average speed of single cells was measured. Supplementary
Movies (Movie 3 and 4) of tracked cells are prepared and available. Error! Reference source not
found.A shows the average speed of single cells in PAM and control samples. This result indicates
that the speed of PAM treated cells is lower than that of the control, which indicates PAM treatment
decreases average cell migration speed. Results of an independent t-test indicates that speed of
single cells in PAM treated sample (mean = 16.78 µm/h, SD= 3.27 µm/h) is statistically
significantly lower than the control (mean = 23.23 µm/h, SD= 3.43 µm/h), t(37) = 5.994, p < 0.001.
Error! Reference source not found.B and C show the trace of a cell migration in a control and
PAM treated sample, respectively. These visually indicate that a single cell in the control sample
trailed a wider area and the cell migration is more pronounced compared to the traced cell in PAM
sample.
Cell-cell and cell-matrix adhesion are essentials in the architecture of epithelial cells. Molecular
complexes control both types of adhesion and interact with the extracellular environment and
regulate cell cytoskeleton organization [106]. Cell-cell and cell-matrix adhesion play an
important role in cell migration and tissue integrity and a disruption in the function of these two
can affect cell migration. Immunofluorescence experiments were then performed to determine if
any adverse effects on the actin and adhesion apparatus of MDCK cells underlies the decreased
migration speed. Comparing immunostaining images in both PAM and control samples in
A-D reveals that both beta-catenin and paxillin (markers of cell-cell and cell-substrate adhesion,
respectively) were expressed and distributed similarly. Likewise, the overall filamentous actin
organization in the control and PAM treated samples did not differ significantly as can be seen in
immunofluorescence images from marked filamentous actin in
E-F. According to the immunofluorescent result, PAM treatment does not damage or interrupt cellcell and cell-substrate adhesions neither actin structures in MDCK cells. Since these morphological
properties were not affected adversely by PAM treatment they may not be associated with the
decreased cell migration.
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Figure 33. A) The average speed of single cells tracked in the time-lapse movies of PAM and
control MDCK samples. Data represent an average in µm/h from 8 tracked cells of two
independent experiments: means ± SD. *** p<0.001 (independent t-test). Trace of a cell migration
during time-lapse imaging is labeled by red color in B) control sample and C) PAM treated sample.
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Figure 33. (Continued).
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Figure 34. Morphological characterization of MDCK cells: A) and B): immunofluorescence
staining with anti-Beta-catenin to mark cell-cell adhesion of control and PAM treated samples,
respectively. The expressions of bright lines in cell-cell borders are similar in both control and
PAM treated samples indicating that moderate PAM treatment does not interrupt cell-cell adhesion
in MDCK cells. C) and D): Immunofluorescence staining with anti-paxillin to mark cell-surface
adhesion in control and PAM treated samples, respectively. PAM treatment does not reduce cellsurface adhesion since anti-paxillin markers are expressed and distributed similarly in both control
and PAM treated samples. E) and F): Phalloidin-488 was used to mark filamentous actin in control
and PAM treated samples, respectively. PAM treatment does not interrupt actin filaments as the
marked actin filaments in PAM treated sample are distributed and localized similar to control
sample and there is no evidence of under-expression or disruption.
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Figure 34. (Continued).
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Figure 34. (Continued).
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IV.5

SUMMARY

In this chapter, effects of PAM treatment on epithelial non-cancerous MDCK cells were
investigated and results of experiments were represented and discussed. PAM treatment affected
cell viability of normal cells in a dose-dependent manner. The result of the MTS assay indicated
that MDCK cells are relatively vigorous against PAM treatment. A similar dose of PAM (4 min)
which induced a widespread cell death in SCaBER cells led to only a minor reduction in MDCK
cells viability. In fact, a 10 minute plasma exposure time is required to observe a similar killing
phenomenon in normal cells. It was shown that lower dose of plasma exposure (3 min and lower)
did not affect viability of cell significantly while, moderate dose of PAM (4 and 6 min) led to a
reduction in cell viability. Two-day time-lapse microscopy was run to monitor effects of moderate
PAM treatment on MDCK cells. The results showed that cells did not multiply like control cells
when they were treated with moderate intensity PAM. The number of cell division events counted
in time-lapse movies showed a lower number in PAM treated samples. Moreover, immunostaining
of MDCK cells showed a lower number of Ki-67 marked cells in PAM treated cells compared to
control cells. All these results were in agreement and indicated that PAM treatment can impact
cell growth in MDCK samples by inhibiting proliferation in cells. In addition, it was observed that
PAM decreased average cell migration speed. Despite cell proliferation and migration inhibitions
in MDCK cells after the PAM treatment, no significant changes were observed in their
morphological characteristics including cell adhesions and actin filaments organization.
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CHAPTER V
CONCLUSION
V.1

SUMMARY AND OUTLOOKS

In this dissertation, effects of low temperature plasma (LTP) treatment on cancerous epithelial
SCaBER cells and normal epithelial Canine Kidney (MDCK) cells were investigated. Epithelial
cells are adherent ones that cover flat surfaces and fill most of the cavities of many organs of the
body. Epithelial cells are different in size and shape but all are tightly packed together with almost
no intercellular spaces. In this research, epithelial cells were grown in vitro overnight to provide
sufficient time for active adherence of cells to the bottom of the plate. In treatment procedures,
cells were exposed to the plasma pencil at different plasma exposure time.
The direct treatment of SCaBER cells suppressed viability of cells in a dose-dependent manner by
manifesting less live cells and higher dead cells at post-treatment times. Moreover, it was proved
that helium gas flow alone does not affect cells viability. In this method, cells adhered to the button
of cell culture plate were covered with cell culture media during plasma exposure. The higher the
exposure time of plasma, the lower the number of cells that survived. A widespread cell death was
observed at 3 min and higher plasma exposure time. The viability assessment immediately after
direct LTP treatment showed that cells were alive which indicates there was no sudden physical
damage to the treated cells. Basically, the interaction between plasma reactive species and cells
requires a sufficient time to show an effect.
Although, the most feasible ways to transport the reactive species from a gas phase plasma to a
target sample is via direct exposure it was shown that using plasma activated media (PAM) can
also be effective in killing cancer cells. Treating a liquid by LTP results in the activation of the
treated liquid by generating or dissolving reactive species in it. Indeed, PAM allows for storage of
long-lived reactive species for a specific time and for later application. This procedure provides an
indirect treatment of a sample. The complete cell culture media used in growing SCaBER or
MDCK cells were used to make PAM. In this research, a standard protocol was used consistently
to make PAM in which, 1 ml of the cell culture media in a 24-well plate were exposed to the
plasma pencil for a designated time. In this application, PAM was used either immediately after
preparation or after a storage time. This is referred to as aged-PAM in this dissertation.
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Results indicated that immediate PAM application inhibits cell viability in SCaBER cells in an
exposure time-dependent manner when PAM covered cells for a sufficient time of 24 or 48 h.
Similar to the direct treatment, increasing the plasma exposure time resulted in lower viable cells
at post-PAM application times. Both methods revealed the capability of plasma-based treatment
in inducing cell death in cancerous SCaBER cells.
On the other hand, the anti-cancer properties of PAM reduced over time and its efficiency in killing
SCaBER cells was decreased by aging. In fact, reactive species in a liquid environment have a
specific lifetime and degradation rate and they can vary depending on parameters like pH,
temperature, and chemical compositions of the treated media. The result of using aged-PAM in
treating SCaBER cells indicated that the killing effect of PAM was reduced over time. In
particular, 2 min PAM efficiency decreases by around 10, 50, and 80 percent when it was aged for
1, 8, and 12 h, respectively. However, it was observed that the trend of the reduction in the
efficiency of aged-PAM was not quite similar for 2, 3, and 4 min PAM. In PAM created by longer
plasma exposure times, such as 4 min, aging did not impact its efficacy and cytotoxicity as it was
as effective as immediate application whereas, 2 min PAM gradually lost its anti-cancer properties.
This indicates that degradations of RONS in 4 min PAM within the 12 h of aging could not decline
their concentration to a tolerable level for SCaBER cells and 4 min PAM was still very toxic to
cells. As a result, the anti-cancer properties of PAM treatment seems to be dependent on the
duration of plasma exposure or aging time which are linked to the concentration and stability of
reactive species in PAM.
Reactive species including oxygen, nitrogen, and free radical species are known to have important
impacts in biological systems. A positive impact would be intracellular signaling in the regulation
of metabolic pathways and a negative impact would for example be the detrimental roles in the
operation of the immune system. Several investigations have reported that RONS are crucially
involved in the anti-cancer properties of plasma-based treatment. Particularly, hydrogen peroxide
is known to be very effective ROS by being able to penetrate the cell membrane. It is one of the
most long-lived species and can be an intermediary in many reactions that produce more ROS.
Therefore, its concentration and stability measurements in PAM and aged-PAM illuminated its
role in the achieved results. Using Amplex-red as a molecular probe revealed that application of
the plasma pencil leads to the creation of a relatively high amount of hydrogen peroxide in PAM.
The concentration of hydrogen peroxide increased with plasma exposure time. As a result, it is the
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concentration of LTP-generated ROS and RNS in PAM which causes the exposure-time dependent
effect of plasma and determines its anti-cancer properties.
As expected, aging of PAM resulted in degradation and reduction of hydrogen peroxide
concentration. Interestingly, the trend of reduction in hydrogen peroxide concentration was similar
to aged-PAM efficiency in killing SCaBER cells. Cell culture media are very complex to study.
Therefore, determining the reactions and the concentrations of RONS induced by plasma exposure
is not a trivial matter. Stability of reactive species is highly dependent on the chemical composition
of media and presence of scavengers. For instance, hydrogen peroxide is reduced into hydroxyl
radical and hydroperoxyl radical in the presence of ferrous ions. The serum added in a cell culture
media contains metallic compounds including ferrous ions. Deletion of serum from PAM resulted
in higher level of hydrogen peroxide. It was shown that the lack of serum in media leads to an
increase of the level of hydrogen peroxide by 50% for 8 h aged-PAM. This result proves the
scavenging role of serum in PAM and more than that, specifies the importance of the chemical
composition of media in modulating the concentrations of ROS and determining the stability of
PAM.
Gas plasma is a cocktail of free radical, ions, electrons and reactive species which interacts with
media during the plasma exposure time. First, species that are created in the gas-phase in plasma
at some distance far away from the media can travel and diffuse into the media, which results in
the activation of the exposed media. Second, at the point where plasma contacts the surface of the
media, species in the gas phase can be dissolved into the liquid and lead to the activation of media.
Finally, UV radiation from the plasma can cause photolysis of the media mainly resulting in the
creation of radical species. All these mechanisms may lead to the formation of ROS and RNS in
media and creation of PAM [107]. Once gas species including electrons, ions, and radicals either
diffuse into or are formed in the media. A series of reactions within the media may occur and in
turn, leads to the creation of more reactive species. Some of the reactions like solvation of electrons
are short-lived while some other products in a liquid have relatively longer lifetimes.
The transport rates of various species from the gas phase into liquid are determined by Henry’s
Law. According to Henry’s Law, at a constant temperature, the number of gas species that
dissolves in a liquid is proportional to the partial pressure of that gas in the vapor phase. Table
2Error! Reference source not found. shows Henry’s Law Constants for water as the solvent. A
larger Henry’s constant (it is dimensionless) means there is a higher possibility that the gas species
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dissolve in a liquid. For instance, H2O2 (Henry’s law constant: 1.92×106) in water will dissolve
faster than OH (6.92×102) and OH faster than O3 (3×10-1).

Table 2. Henry‘s Dimensionless Law Constant [108].

Therefore, formation of a species such as hydrogen peroxide from hydroxyl radical recombination
2•OH → H2O2

(5)

can occur in three different regions: hydrogen peroxide is created in the gas bulk and is transported
to liquid
2•OH(g) + M → H2O2(g) + M

(6)

2•OH(aq) → H2O2(aq)

(7)

or it is created in liquid
or it is created at the interface of gas ̶ liquid and the interfacial reaction leads to incorporation of
the hydrogen peroxide into liquid.
2•OH(in) → H2O2(in).

(8)
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Therefore, one of the questions to be answered is the mechanism of penetration/generation of
hydrogen peroxide in PAM.
In addition to its effect on a cancer cell line, the effect of PAM on normal epithelial cells was
analyzed. Despite the lethal impact of PAM on SCaBER cells, no significant reduction in the
viability of normal MDCK cells was observed. The metabolic activity of MDCK cells was not
meaningfully impacted by 3 min or less PAM. On the other hand, 4 min PAM which resulted in a
log reduction (90%) in viability of SCaBER cells only reduced viability of MDCK cells by 10%.
These results clearly indicate that normal MDCK cells are much more robust against PAM
treatment and seem to be able to tolerate a higher level of oxidative stress. To induce a widespread
cell death in normal cells a longer plasma exposure time was required (10 min). The difference in
the response of cancer and normal cells to PAM treatment refers to their intracellular resources of
antioxidants and their dissimilar metabolic activities. It is known that cancer cells, due to their high
metabolic activities, contain a higher level intercellular ROS and a lower amount of antioxidants.
Therefore, cancer cells can be more vulnerable to an externally enhanced oxidative stress. An
overload of oxidative stress induces severe cellular damage leading to redox state alteration,
defense and repair systems destruction. Consequently, MDCK cells are able to overcome the
oxidative stress induced by PAM treatment while SCaBER cells undergo an irreversible damage.
If cells become unable to restore the oxidative balance, a number of pathological processes are
evoked which are known as apoptotic models including lipid peroxidation, the loss of intracellular
calcium homeostasis, and change in metabolic pathways. On the other hand, an extreme
concentration of external oxidative stress causes necrosis rather than apoptosis [109]. As discussed
in the introduction chapter, some researchers reported that they observed a higher dose of plasma
exposure led to necrotic cell death in different cell types while apoptosis occurred at a lower dose
of plasma exposure. Executioner caspase-3 measurement in SCaBER cells treated by 2 min PAM
did not show an increase in the level of cleaved caspase-3. In addition, the use of caspase-3
inhibitor (DEVD-fmk) did not block cell death. These results indicated that the mechanism of cell
death in SCaBER induced by PAM treatment was caspase-independent. Therefore, the cell injury
can be through necrosis pathway or a caspase-independent apoptosis pathway.
Besides the research on epithelial cells, a molecular beacon was used to evaluate harmful effects
of plasma exposure on DNA. The logic of this experiment is that if plasma exposure causes any
rapture in the stem of the treated DNAoligo, an immediate separation of the fluorophore–quencher
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pairs leads to spontaneous fluorescent illumination. Hence, the measured fluorescence intensity
correlates to the amount of damaged DNA units. This result indicated that LTP treatment induces
breaks in DNA structure in an exposure time-dependent manner: a higher dose of plasma treatment
leads to damage in more MB units.
To achieve a better understanding of the PAM interaction with normal cells time-lapse imaging
and immunofluorescent assays were used to evaluate cell morphology and proliferation. MDCK
cells cultured in a 24-well plate were treated with a moderate level of PAM (5 min) and a sequence
of images taken every 10 min was recorded using time-lapse microscopy. Results demonstrated
that cells in the control sample multiplied during the 48 h of imaging and cell islands were
expanded while the number of cells in the PAM treated sample did not increase in population
likewise. Monitoring of PAM treated and control MDCK cells suggests that it is likely that PAM
application inhibits proliferation in normal cells rather than killing or harming cell morphology.
To clarify what phenomenon (proliferation inhibition or cell death) was dominant in the
diminished cell population, the numbers of dividing cells were manually counted in each movie.
The result showed the number of dividing events (cell division) decreased by around 75% in PAM
treated samples. This indicates that cell proliferation was significantly reduced in PAM treated
cells and confirmed the visual observation of time-lapse imaging. Consequently, mitigation in the
cell growth was associated with cell proliferation inhibition rather than widespread cell death.
Active phases of a cell cycle are G1 (growth and metabolism phase), S (DNA replication phase),
G2 (growth of structural elements and preparation for mitosis), and M (mitosis or cell division)
and G0 is the resting phase. Ki-67 is a protein that is present in all active phase but it is absent in
the G0 phase. Marking of this protein is a method to identify cell proliferation activity in PAM
treated cells compared to control. The result of immunostaining showed that the number of marked
cells with Ki-67 is higher in control than PAM sample. In fact, the percentage of stained cells in
the control sample was 1.7 times higher than that for the PAM treated cells and it supports the
lower rate of cell proliferation in PAM samples as observed using time-lapse imaging and the
lower rate of cell division.
In addition, it was observed that PAM decreased average cell migration speed. Single cells within
the MDCK islands were tracked in the control and PAM time-lapse sequences and the average
speed of single cells was measured. This result indicated that the speed of PAM treated cells is
about 25% lower than that of the control.
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A reduction in cell-cell and cell-substrate adhesion can affect cell migration and tissue integrity.
For this reason, immunofluorescence assays were performed to determine if PAM treatment
induces any adverse effects on the cell-cell adhesion, cell-substrate adhesion, and actin filament
structures of MDCK cells. Despite cell proliferation and migration inhibitions in MDCK cells, no
significant changes were observed in their morphological characteristics after the PAM treatment.
Beta-catenin is a protein from the complex family of cadherin which regulates and coordinates
cell–cell adhesion. Paxillin is a protein that is expressed in focal adhesions of non-striated cells
and its role is to regulate cell-substrate adhesion. Actin is a group of proteins which are
polymerized to form actin filaments in the cytoskeleton of eukaryotic cells. An immunostaining
assay was used to mark and visualize these proteins to evaluate whether their expressions are
reduced or disrupted after PAM treatment. Immunostaining images in both PAM and control
samples revealed that both beta-catenin and paxillin were expressed and distributed similarly
which means PAM treatment did not impact the cell adhesion apparatus. Likewise, the overall
filamentous actin organization in the control and PAM treated samples did not differ significantly.
Therefore, PAM treatment does not damage or impact morphological properties of MDCK cells
and these may not be associated with the decreased cell migration.

V.2

RECOMMENDATION FOR FUTURE WORK

The results indicated that PAM is capable of inducing cell death in urinary bladder carcinoma cells
while the same dose of PAM does not significantly impact viability and morphology of normal
canine kidney epithelial cells. These preliminary achievements are very important and encouraging
to continue the research on the anti-cancer effects of PAM. Other cell lines or primary cell types
can be studied to advance this research. Each cell type has different resources and characteristics.
Therefore, they will respond differently to PAM treatment and the exact same results may not
necessarily be observed. Hence, extensive research on various types of cancer cell lines will help
to gain a better understanding how practically PAM treatment can be effective in cancer therapy.
The concentration and stability of H2O2 was measured in PAM. The results indicated the important
role hydrogen peroxide plays in killing SCaBER cells by showing that there is a correlation
between H2O2 concentration and PAM effectiveness. Identifying and measuring concentrations of
other reactive oxygen and nitrogen species which have important biological impacts is the next
step. There are several designated assays to measure the level of reactive species in the liquid
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phase, quantitatively. It is suggested to identify and measure the concentration of other important
reactive species such as ozone, superoxide onion, peroxynitrite, and nitric oxide in PAM. This
research will help determine what species and reactions are essential for PAM effectiveness.
Moreover, knowing the relation between ROS level and cytotoxic effects of PAM can be used to
modify PAM in order to reach a desired result.
An increment in the level of caspase-3 activity was not observed in SCaBER cells treated by 2 min
PAM and it was concluded that cell death was caspase-independent. Work can be conducted to
identify the mechanism of SCaBER cell injury to understand if it is through a necrosis pathway or
through a caspase-independent apoptosis such as mitochondrial-mediated or lysosomal membrane
permeabilization.
Finally, it is suggested that the level of intracellular ROS should be studied. An analysis of the
temporal evolution in extracellular ROS (hydrogen peroxide) in PAM was performed but changes
in the level of intracellular ROS was still unknown. There are reagents that can be used to detect
and quantify concentrations of RONS in permeabilized or live cells by fluorescein instruments
such as microscopes and fluorescent microplate readers. Evaluating level of intracellular ROS and
locations where they are expressed more is a complex process but very important in order to gain
a deeper understanding of the interaction of cells with oxidative stress in PAM.
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APPENDIX A
EFFECT OF PLASMA ON DNAOLIGO
LTP-generated RONS can either directly penetrate into cells through their membranes or react
with cell membrane and the by-products of the membrane peroxidation reaction diffuse into the
cells. Either of these mechanisms leads to the reaction of RONS with intracellular macromolecules,
interruption in cell signaling pathways, and finally cell organelles damage such as compromising
the integrity of the DNA structure [1-3]. DNA damages are in the form of single-strand breaks
(SSBs) and double-strand breaks (DSBs) [2, 4, 5]. To investigate the DNA damage induced by the
plasma pencil, a molecular beacon (MB) was used. Molecular beacons are single strand DNA
oligonucleotide which adopts a stem-and-loop shape. The 5ʹ end of the stem is connected to a
fluorophore moiety and the 3ʹ end is connected to a quenching moiety. The stem of MB keeps the
two moieties close together; however, a rapture in the stem results in an immediate separation of
the fluorophore–quencher pairs and leads to spontaneous fluorescent illumination [6]. The
intensity of illumination is correspondent to the extent of DNA cleavage. Figure shows a schematic
of a molecular beacon and the mechanism of fluorescent illumination.

Figure 35. The schematic diagram of the molecular beacon: the blue ball represents a fluorophore
(FAM) and the green ball represents a quencher (BHQ-1). Any cleavage in the stem results in the
separation of the pair and emission of fluorescent signals [6].
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The MB DNA probe was purchased from Eurofins Genomics Company (Virginia, USA) in HPLC
(High Performance Liquid Chromatography) purification with the following structure:
[6-FAM]-5′GCACTGAAGCGCCGCACGCCATGTCGACGCGCTTCAGTGC–3′-[BHQ1].
FAM and BHQ-1 are the fluorescent dye and the quencher, respectively. The underlined letters
indicate the stem sequences. In this experiment, a 100 nM MB solution was prepared in 0.1 M
sodium phosphate buffer (NaH2PO4), pH 7.4 (Molecular Toxicology, Inc.). The MB solution was
heated up to ~87 °C for 3 min in a heat block. Then, MB solution was stored in the dark to provide
a gradual temperature reduction in 3 h. This cooling process results in correct stem-loop formation.
Next, 400 µl of MB solution was added in an eppendorf tube and was exposed to the plasma pencil
for 15 s, 30 s, 1, 2, 3, 4, and 5 min. The distance from the tip of the nozzle to the surface of the
liquid was 26 ± 1 mm. Plasma operating conditions were the same as mentioned in Section II.1.1.
A control sample was treated with the helium gas without plasma ignition for 5 min. 100 µl of the
control and LTP-treated samples were transferred to each well of a black opaque 96-well plate and
the fluorescence intensity was measured using a fluorescence microplate reader (BMG Labtech
FLUOstar) with the excitation and emission wavelengths of 495 and 520 nm, respectively.
Figure indicates fluorescence intensity collected from control and MB solutions treated directly by
plasma pencil. As this figure shows, the fluorescence intensity increases by increasing the LTP
exposure time. This result indicates that LTP treatment induces breaks in DNA structure and a
higher dose of plasma treatment leads to damage in more MB units. However, this method does
not provide further information about the type of damage as single-strand or double-strand breaks.
Nor does it determine the number of breaks in a single MB unit. In fact, one break in the DNA
stem of the MB is enough to emit fluorescence and more than one break in one MB unit cannot
enhance the intensity of emission.
Kurita et al. [1] reported that atmospheric pressure plasma jet induced DNA damage in molecular
beacon and the fluorescent emission intensity was proportional to the plasma exposure time and
the power of plasma source. Among the different types of DNA damage, double-strand breaks
(DSBs) are the most dangerous. Since both strands of the DNA double helix are simultaneously
broken in this case, the repair process is more difficult. Also, there is a higher possibility of
inappropriate rejoining which causes genome instability. Without proper DNA repair, such
damages can result in permanent cell cycle arrest or apoptotic cell death [7]. Double-strand breaks
can be repaired via pathways including homologous recombination (HR) and non-homologous end
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joining (NHEJ) [8]. Research on inducing double-strand DNA breaks due to LTP treatment
showed that air plasma is more efficient in causing DSBs that N2 plasma and atomic oxygen plays
the major role among other RONS [5].
Both nucleobases and deoxyribose sugar of DNA are susceptible to be attacked by ROS/RNS. In
fact, O2˙− and H2O2 are not able to directly induce DNA strand breaks or modify nucleobase under
physiological conditions. It has been reported that H2O2 treatment of eukaryotic cells resulted in
DNA strand breakage, but the damage was negated in the presence of ˙OH scavengers. Therefore,
it is likely that ˙OH is involved in DNA strand breakage and O2˙−and H2O2 in vivo will convert
into ˙OH radicals via the Fenton reaction [4].
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Figure 36. Breaks in molecular beacon was analyzed by measuring the fluorescence intensity as a
function of exposure time. Data represent the mean ± SD of two independent experiments.

97
REFERENCES
[1]

H. Kurita, S. Miyachika, H. Yasuda, K. Takashima, A. Mizuno, "Use of molecular beacons
for the rapid analysis of DNA damage induced by exposure to an atmospheric pressure
plasma jet," Applied Physics Letters. 2015, 107, 263702.

[2]

K. Kim, J. D. Choi, Y. C. Hong, G. Kim, E. J. Noh, J. S. Lee, S. S. Yang, "Atmosphericpressure plasma-jet from micronozzle array and its biological effects on living cells for
cancer therapy," Applied Physics Letters. 2011, 98, 073701.

[3]

G. J. Kim, W. Kim, K. T. Kim, J. K. Lee, "DNA damage and mitochondria dysfunction in
cell apoptosis induced by nonthermal air plasma," Applied Physics Letters. 2010, 96,
021502.

[4]

K. Arjunan, V. Sharma, S. Ptasinska, "Effects of atmospheric pressure plasmas on isolated
and cellular DNA—A review," International Journal of Molecular Sciences. 2015, 16,
2971.

[5]

Y. Lee, K. Kim, K. T. Kang, J. S. Lee, S. S. Yang, W. H. Chung, "Atmospheric-pressure
plasma jet induces DNA double-strand breaks that require a Rad51-mediated homologous
recombination for repair in Saccharomyces cerevisiae," Archives of Biochemistry and
Biophysics. 2014, 560, 1.

[6]

J. B. Biggins, J. R. Prudent, D. J. Marshall, J. S. Thorson, "A continuous assay for DNA
cleavage using molecular break lights," Methods in Molecular Biology (Clifton, N.J.).
2006, 335, 83.

[7]

D. Branzei, M. Foiani, "Regulation of DNA repair throughout the cell cycle," Nature
Reviews Molecular Cell Biology. 2008, 9, 297.

[8]

E. Sonoda, H. Hochegger, A. Saberi, Y. Taniguchi, S. Takeda, "Differential usage of nonhomologous end-joining and homologous recombination in double strand break repair,"
DNA Repair. 2006, 5, 1021.

98

APPENDIX B
PERMISSIONS FROM THE COPYRIGHT HOLDER

99

100

101

102

103

104

105

106

107

108

109

110

VITA
Soheila Mohades was born in Karaj, Iran. She received her B.S. degree in Physics from Shahid
Beheshti University, Tehran, Iran in 2008 and her M.S. degree in Plasma Engineering from the
Laser and Plasma Research Institute of Shahid Beheshti University in 2012. She joined Dr.
Laroussi’s group in the Plasma Engineering and Medicine Institute (PEMI) at Old Dominion
University as a graduate assistant in 2012. She studied biomedical applications of low temperature
plasma and cancer treatment for her Ph.D. research. She has authored and co-authored 7 papers in
top peer-reviewed scientific journals and presented more than 10 oral and poster presentations in
scientific conferences. She has been a member of IEEE and WIE (Woman in Engineering) since
2014. Soheila Mohades received the Engineering Dean’s Graduate Fellowship Award for
Excellence from the Batten College of Engineering and Technology of Old Dominion University
in 2015. She was a recipient of Student Travel Award to present her work at the Gaseous
Electronics Conference (GEC) held in Raleigh, North Carolina in 2014. She also received the best
PhD researcher award of the year from the Electrical and Computer Engineering Department of
Old Dominion University in 2017.

